Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.7;WM-115: 4.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	41000	41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.3	0.1	0.3	0.3	0.2	0.0	1.0	0.3	0.4	0.5	0.1	0.0	0.0	0.8	0.9	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.5	0.2	0.4	1.0	0.3	0.2	0.3	0.0	6.7	0.7	0.1	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell line enriched"	"Detected in single"	9	"HSkMC: 5.7"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051039	Enhanced									"HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TNNT3	"AMCD2B, DA2B, DKFZp779M2348, FSSV"	ENSG00000130595	"Troponin T3, fast skeletal type"	P45378	11	1919562-1938706	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"skeletal muscle: 834.7;tongue: 355.7"	"Cell line enriched"	"Detected in some"	21	"HSkMC: 32.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 28.8;urothelial cancer: 19.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002451, HPA037810, HPA056909"	Enhanced									"CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273"	"unprognostic (1.01e-2)"	"prognostic favourable (7.37e-4)"	"unprognostic (2.17e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.53e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.42e-5)"	"unprognostic (2.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.90e-2)"	15.6	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.3	4.4	7.5	0.6	0.2	4.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.9	0.0	1.4	0.1	0.0	12.1	0.3	834.7	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.0	0.0	4.1	355.7	10.1	1.2	0.6	0.0	0.9	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.2;NB-4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					12000000	12000000			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.7	0.8	0.3	8.2	0.6	0.6	0.2	0.0	1.5	1.5	0.0	2.1	1.4	4.7	1.7	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	0.7	0.9	0.6	0.0	0.9	0.3	0.1	2.3	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549957	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 559.4;tongue: 232.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.0;HSkMC: 2.9;NTERA-2: 12.8"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001349, CAB010760"	Enhanced					42000000	42000000			"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.6	0.1	559.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	232.5	11.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	12.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315190	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 743.1;tongue: 350.7"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 33.8"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	20000000	20000000			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavourable (6.59e-4)"									"unprognostic (1.88e-1)"			12.9	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	16.1	9.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	13.4	0.0	743.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.4	350.7	9.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39664187-39666555	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2"	"Cell line enhanced"	"Detected in many"		"NB-4: 6.8;SK-BR-3: 11.8"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.0"	"Low region specificity"	"Detected in many"			"CAB004591, HPA026477"	Enhanced					68000	68000			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (4.55e-4)"	3.2	0.2	0.2	0.1	0.5	0.2	0.2	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.1	11.1	8.6	0.1	0.1	298.7	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.1	0.2	0.1	0.2	0.1	0.0	4.1	0.1	0.0	12.3	0.1	708.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	5.8	249.2	11.5	0.2	0.1	0.3	0.0	0.0	0.2	0.3	2.4	0.1	0.2	3.1	2.4	3.6	0.5	0.5	0.8	0.5	0.1	0.5	0.8	1.2	2.1	1.3	2.5	0.3	1.3	1.1	0.1	0.2	1.1	3.1	1.3	1.6	0.3	0.7	0.7	0.4	1.0	0.6	1.0	0.3	0.2	2.4	0.8	0.2	1.3	1.0	6.8	1.6	0.8	1.0	2.5	0.8	0.5	0.4	1.5	2.4	1.7	11.8	1.4	0.8	1.4	1.2	1.0	1.7	2.2	0.7	5.2	2.9	0.7	1.1	1.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	2.4	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.5	0.4	0.2	0.2	0.2	0.6	0.0	0.0	0.0
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	34	"cerebellum: 1.8"	HPA059196	Uncertain									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOT	"LGMD1, LGMD1A, TTID"	ENSG00000120729	Myotilin	Q9UBF9	5	137867791-137887851	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	30	"skeletal muscle: 297.3;tongue: 85.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 2.4;U-266/70: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037733, HPA037734"	Enhanced									"HPA037733: AB_10697082, HPA037734: AB_2675638"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.85e-4)"	"unprognostic (8.03e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.56e-4)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	2.8	0.3	0.6	0.2	1.4	0.1	0.1	0.1	0.4	0.3	1.0	0.0	0.0	0.3	0.1	6.0	6.2	0.1	0.2	6.2	0.7	0.4	0.2	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.4	0.3	0.0	3.6	0.6	297.3	0.1	0.4	0.2	0.7	0.1	0.2	0.1	0.6	0.0	2.2	85.1	6.0	0.2	0.4	0.8	1.0	0.0	0.1	0.4	0.6	0.0	0.5	0.3	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	1.1	1.1	0.0	0.1	0.0	0.3	0.0	0.5	1.5	0.4	2.4	0.0	0.0	0.0	0.3	1.4	0.4	0.0	0.0	0.0	0.2	1.1	1.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.7	0.0	0.8	0.0	0.2	0.6	0.1	0.5	0.0	0.0	1.7	0.7	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.5	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.6	1.4	0.1	0.4	0.7	0.4	0.9	0.0	0.1	0.6
CALML6	CAGLP	ENSG00000169885	"Calmodulin like 6"	Q8TD86	1	1914827-1917296	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"skeletal muscle: 51.4;tongue: 73.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"														"unprognostic (3.85e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.59e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.76e-2)"	"unprognostic (5.21e-10)"	"unprognostic (5.06e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.48e-2)"	0.2	0.0	0.1	0.1	0.6	0.1	0.2	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	0.0	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.3	0.1	0.1	0.7	0.1	0.1	1.8	0.2	51.4	0.8	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	73.7	0.7	0.1	0.5	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	4.9	1.5	0.9	2.9	1.0	0.0	0.4	0.5	0.0	2.9	0.9	0.1	1.2	1.5	0.3	0.5	0.0	0.7	0.3	0.0	1.1	0.0	0.4	0.1	0.6	2.1	2.9	0.4	0.3	0.2	0.0	1.7	0.1	1.0	0.0	0.1	0.9	0.8	1.5	0.1	2.5	0.5	0.2	0.2	0.5	0.0	0.3	0.1	0.8	0.3	0.0	0.1	0.0	2.7	0.1	1.5	0.3	2.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.6	0.7	0.3	0.1	0.0	0.1	0.1	0.1	0.1
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428428	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 14.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	125	"NK-cell: 12.5"	"Lineage enriched"	"Detected in single"	125	"NK-cells: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			3.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.8	0.1	0.0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	5.5	230.8	11.4	0.1	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0
MYLPF	"HUMMLC2B, MRLC2, MYL11"	ENSG00000180209	"Myosin light chain, phosphorylatable, fast skeletal muscle"	Q96A32	16	30370934-30377991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"skeletal muscle: 689.9;tongue: 215.7"	"Group enriched"	"Detected in some"	18	"BEWO: 25.5;HSkMC: 57.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	71	"plasmacytoid DC: 16.5"	"Lineage enriched"	"Detected in single"	71	"dendritic cells: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039262, HPA055059"	Enhanced					28000	28000			"HPA039262: AB_2676418, HPA055059: AB_2732591"	"unprognostic (8.81e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.88e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.44e-2)"	16.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.1	5.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	10.4	0.0	689.9	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	215.7	5.8	0.0	0.0	0.1	16.5	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	16.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SBK2	SGK069	ENSG00000187550	"SH3 domain binding kinase family member 2"	P0C263	19	55529733-55537089	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"heart muscle: 45.7;tongue: 20.8"	"Cell line enhanced"	"Detected in some"		"A549: 4.3;Hep G2: 3.1;MCF7: 4.4;NTERA-2: 8.7;RH-30: 8.1;U-2 OS: 4.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030631	Enhanced									"HPA030631: AB_10602088"	"unprognostic (1.33e-1)"			"unprognostic (1.85e-3)"	"unprognostic (4.57e-1)"	"unprognostic (3.49e-1)"				"unprognostic (5.43e-3)"	"unprognostic (4.18e-3)"		"unprognostic (2.08e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.05e-1)"			0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.7	20.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	1.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	8.7	0.0	0.0	8.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Low region specificity"	"Detected in all"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.7	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.5	4.1	1.1	0.6	0.5	0.2	5.1	6.5	0.3	9.7	10.9	6.1	9.6	7.4	16.8	6.8	5.7	0.0	0.6	6.1	4.9	3.3	4.5	3.4	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.7	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 61.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.4"	"Not detected"	"Not detected"							"CAB000060, HPA003123"	Enhanced					190000000	190000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	3.6	0.1	0.2	0.1	0.2	0.0	1.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.0	19.6	0.4	0.0	366.6	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.3	0.1	0.0	5.0	0.3	0.0	13.0	0.0	871.2	0.3	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0.0	4.4	0.7	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.2	0.0	0.8	0.3	0.1	2.6	0.0	2.2	0.5	0.0	6.5	61.5	0.0	13.7	0.0	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
KRTAP3-3	KAP3.3	ENSG00000212899	"Keratin associated protein 3-3"	Q9BYR6	17	40993430-40994133	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	25	"skin 1: 50.5;tongue: 29.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Supported									"HPA042992: AB_2678258"																		0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.0	0.3	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MYOZ1	"CS-2, FATZ, MYOZ"	ENSG00000177791	"Myozenin 1"	Q9NP98	10	73631654-73641757	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"skeletal muscle: 387.8;tongue: 133.0"	"Cell line enriched"	"Detected in some"	18	"BEWO: 29.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"olfactory region: 4.9"	"Low region specificity"	"Detected in all"			"HPA037848, HPA038437"	Enhanced									"HPA037848: AB_10670156, HPA038437: AB_2676009"	"unprognostic (4.55e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.09e-1)"	8.1	0.1	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	10.9	4.2	0.1	0.1	4.1	0.2	0.2	0.2	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.4	0.0	1.3	0.1	0.0	5.6	0.3	387.8	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	1.4	133.0	5.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.3	0.7	0.2	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0
SMPX	"DFN6, DFNX4"	ENSG00000091482	"Small muscle protein, X-linked"	Q9UHP9	X	21705972-21758163	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077360			Approved	"Plasma membrane"		45000	45000	"Plasma membrane"	"Plasma membrane"	"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	1.4	0.0	0.1	0.6	0.1	0.0	0.2	0.6	0.9	0.1	4.0	0.0	0.0	0.1	0.1	4.7	4.0	0.1	0.1	108.8	0.1	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.5	0.0	3.6	0.1	155.8	0.0	0.9	1.8	0.1	0.0	1.5	0.1	0.0	0.0	1.0	74.5	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0.0	0.0
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506877-196515366	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	22	"heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	48.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	2.1	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	66.9	2.5	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.5	0.5	0.4	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPRR2G		ENSG00000159516	"Small proline rich protein 2G"	Q9BYE4	1	153149582-153150869	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"skin 1: 128.3;tongue: 274.6"	"Cell line enriched"	"Detected in single"	17	"hTCEpi: 8.8"	"Group enriched"	"Detected in many"	15	"head and neck cancer: 256.0;melanoma: 131.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"																					"unprognostic (3.93e-1)"				"unprognostic (1.90e-1)"		"unprognostic (3.25e-1)"	"unprognostic (2.44e-1)"								"unprognostic (1.69e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	5.4	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	4.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	128.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	274.6	9.3	0.1	5.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791297	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1"	"Group enriched"	"Detected in some"	28	"BJ hTERT+: 4.4;HeLa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"										"unprognostic (6.83e-2)"													0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	2.7	0.0	87.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	40.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		450000	450000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
ART1	"ART2, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	20	"skeletal muscle: 50.9;tongue: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain									"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		1.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.1	50.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	13.7	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.4	0.0
DUSP27		ENSG00000198842	"Dual specificity phosphatase 27, atypical"	Q5VZP5	1	167094045-167129165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2"	"Cell line enriched"	"Detected in some"	10	"RH-30: 17.7"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012912			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	2.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.1	46.8	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.0	0.9	0.0	64.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	18.2	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526262	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 564.4;tongue: 157.3"	"Group enriched"	"Detected in some"	9	"HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	12.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.0	3.9	0.1	0.0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0.0	0.0	2.0	157.3	5.0	2.1	0.1	0.2	0.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	12.5	0.2	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell line enriched"	"Detected in single"	64	"THP-1: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Low region specificity"	"Detected in some"			"HPA070440, HPA073138"	Enhanced									"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT36	KRTHA6	ENSG00000126337	"Keratin 36"	O76013	17	41486136-41492546	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"tongue: 109.3"	"Cell line enriched"	"Detected in single"	15	"Karpas-707: 8.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									150000000	150000000				"unprognostic (4.39e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.85e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.11e-2)"	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.3	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.6	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.5	0.1	0.1	5.6	0.3	0.1	0.1	1.6	0.0	0.6	0.1	1.9	0.1	109.3	5.1	0.1	1.4	0.0	0.8	0.0	2.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MYOZ3	"CS-3, CS3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660874-150679365	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"skeletal muscle: 81.2;tongue: 79.7"	"Group enriched"	"Detected in some"	4	"HAP1: 5.8;NTERA-2: 10.3;REH: 15.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039166	Enhanced									"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.7	0.3	0.3	0.1	1.4	0.4	0.2	0.2	0.9	0.8	0.2	0.1	0.0	0.2	0.6	3.4	2.3	0.4	0.6	2.0	0.3	2.1	0.2	0.1	0.4	0.1	1.1	0.7	0.4	0.1	0.1	0.7	0.1	0.8	1.7	0.1	1.3	3.8	0.5	81.2	0.1	0.4	0.4	1.9	0.1	0.3	1.8	0.1	0.0	0.3	79.7	4.3	0.2	0.2	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	5.8	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.6	1.5	10.3	0.0	15.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.4	0.2	0.9	0.3	2.1	1.1	0.7	0.8	0.1
PERM1	"C1orf170, MGC13275, Perm1, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;HaCaT: 4.4;MCF7: 3.0;SK-BR-3: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA031711, HPA031712"	Enhanced									"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.0	0.0	23.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.9	0.0	68.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	24.7	0.9	0.1	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.4	1.5	0.0	0.5	0.0	4.4	0.0	0.0	0.0	1.4	0.5	0.0	1.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.9	0.0	0.1	1.3	4.6	1.0	0.4	0.0	0.9	0.7	0.9	0.0	0.7	0.5	0.0	0.0	1.8	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP11-1	KAP11.1	ENSG00000182591	"Keratin associated protein 11-1"	Q8IUC1	21	30880644-30881555	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skin 1: 60.7;tongue: 18.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 1.3;urothelial cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.3"	HPA054008	Enhanced					3800000	3800000			"HPA054008: AB_2682341"																		1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.3	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABRA	STARS	ENSG00000174429	"Actin binding Rho activating protein"	Q8N0Z2	8	106759483-106770245	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 21.6;skeletal muscle: 77.6;tongue: 35.0"	"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (9.08e-3)"	"unprognostic (1.61e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.35e-2)"		"unprognostic (6.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.15e-2)"		"unprognostic (4.34e-1)"	"unprognostic (6.21e-3)"	1.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.3	0.1	0.0	0.8	0.1	0.6	1.7	2.1	0.2	0.1	21.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.6	0.7	0.1	0.0	2.6	1.6	77.6	0.1	0.1	0.5	0.1	0.1	0.1	0.9	0.0	0.0	2.6	35.0	1.2	0.6	2.2	0.7	0.5	2.6	0.6	0.6	0.5	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.2	0.0	0.2	0.0	0.5	0.1	0.4	0.0	0.0	0.7	0.4	0.4	0.1	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.6	0.5	0.3	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.2	0.0	1.2	0.2	0.6	0.1	0.1	0.1	0.2	0.6	1.3	0.1	0.4	0.0	0.2	0.4	0.1	0.2	0.7	0.5	0.5	2.6	0.6	0.5	0.5	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.0
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Group enriched"	"Detected in some"	9	"BEWO: 10.4;HDLM-2: 19.8;RT4: 35.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007845, CAB015170, HPA026823"	Enhanced		Uncertain	Nucleoplasm,Mitochondria	"Intracellular and membrane"			"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	19.8	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.1	0.0	35.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.1	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell line enriched"	"Detected in some"	6	"HEL: 12.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.1	0.6	1.1	1.0	1.2	0.6	0.7	1.5	0.5	0.4	0.5	1.0	1.0	1.6	0.8	1.9	0.2	0.4	0.7	0.2	0.6	12.4	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.5	0.1	0.1	0.3	0.5	0.1	1.3	0.2	0.0	0.9	0.0	0.0	0.8	0.3	1.0	0.6	0.3	0.2	0.5	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.2	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3"	"Cell line enriched"	"Detected in single"	13	"HSkMC: 9.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	26000	26000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.1	0.1	0.2	0.2	0.2	0.0	0.4	0.1	1.0	0.8	0.3	0.0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.2	0.2	9.6	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1.0	0.2	0.2	0.3	0.2	0.4	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell line enriched"	"Detected in some"	23	"RH-30: 224.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA039285: AB_2676427, HPA039527: "	"unprognostic (6.16e-2)"	"prognostic favourable (2.01e-4)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.0	1.6	9.6	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.5	0.1	3.4	0.0	0.1	1.2	224.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.1	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
IL36A	"FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553"	ENSG00000136694	"Interleukin 36 alpha"	Q9UHA7	2	113005461-113008044	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"esophagus: 106.0;lymphoid tissue: 87.9;tongue: 90.7"	"Group enriched"	"Detected in some"	5	"MOLT-4: 4.1;REH: 1.6;U-266/70: 4.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 8.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Not detected"	"Not detected"												"Secreted to blood"							"unprognostic (1.37e-1)"				"unprognostic (9.66e-3)"		"unprognostic (5.46e-1)"										0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	106.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	87.9	0.0	4.8	0.0	0.0	0.0	0.0	0.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	4.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.3	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588716-113664127	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA037953, HPA037954"	Enhanced									"HPA037953: AB_2675755, HPA037954: AB_10672394"	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		5.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.4	5.8	0.0	0.0	74.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.0	4.2	0.0	268.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.8	82.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 86.0"	"Cell line enhanced"	"Detected in some"		"A-431: 1.2;HaCaT: 1.6;U-251 MG: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"gdTCR: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported					79000000	79000000			"HPA039714: AB_2676641"		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	86.0	3.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell line enriched"	"Detected in single"	38	"RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100A7A	"S100A15, S100A7f, S100A7L1"	ENSG00000184330	"S100 calcium binding protein A7A"	Q86SG5	1	153416524-153423225	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 178.1"	"Cell line enriched"	"Detected in single"	8	"SK-BR-3: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006997	Supported		Uncertain	Cytosol				Cytosol	Cytosol	"HPA006997: AB_1079860"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-1)"				"unprognostic (3.73e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"				"unprognostic (1.17e-1)"			"unprognostic (4.40e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	178.1	12.5	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139292139	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;HSkMC: 4.6;REH: 3.8;RPMI-8226: 5.3;U-698: 10.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	4	"B-cells: 5.3;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced									"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1.0	0.7	0.6	0.0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1.0	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1.0	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	1.0	0.1	0.0	0.0	2.0	0.3	4.6	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.3	0.7	0.8	0.2	0.5	3.8	1.7	5.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.9	2.2	1.4	0.1	0.1	0.0	0.1	1.2	2.0	10.1	0.3	2.0	0.0	0.0	0.2	0.0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053304-41064511	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.9;HSkMC: 3.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014252, HPA017957"	Enhanced									"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	1.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	6.1	2.8	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	1.6	0.0	0.1	3.2	0.0	163.0	0.2	0.2	0.4	0.0	0.0	2.2	0.5	0.0	1.3	0.5	53.9	4.2	0.1	0.0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0.0	0.5	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.0	0.6	0.0	1.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.5	0.5	0.1	0.1	0.0	1.2	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0.0	1.3	2.0	3.6	4.4	1.3	3.5	4.3	4.0	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233285-81266397	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;BEWO: 5.9;Hep G2: 5.1;HHSteC: 3.9;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051880	Enhanced					3200000	3200000			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	2.5	5.0	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3.0	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2.0	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0.0	3.3	103.6	2.9	1.0	0.6	0.4	0.1	0.0	0.4	3.8	0.3	0.0	0.1	0.9	0.0	0.9	3.6	0.7	5.9	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	3.1	0.0	0.7	5.1	3.9	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.2	0.1	0.7	0.4	0.8	0.9	0.0	0.0	0.1	0.7	0.7	0.5	0.4	0.8	9.5	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.2	0.0	3.8	0.0	0.1	0.2	0.0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol				Cytosol	Cytosol	"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.6	0.7	0.1	0.0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.4	1.0	0.0	54.0	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	18.1	1.4	0.0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2.0	2.3	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.1	2.1	4.0	0.9	0.0	4.8	0.0	0.0	0.4	0.7	5.3	2.2	5.6	1.8	0.0	1.3	0.9	0.1	0.2	0.0	0.6	0.0	2.0	3.6	0.0	1.2	0.7	2.3	1.8	1.0	1.3	1.5	1.0	0.2	2.2	1.9	1.6	1.0	1.0	1.5	1.6	1.7	0.8	2.9	1.5	1.0	1.8	8.3	3.5	1.4	1.8	4.8	0.7	2.3	0.8	0.8	1.0	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skin 1: 57.5;tongue: 16.1"	"Cell line enriched"	"Detected in some"	5	"A549: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA049778	Supported					160000000	160000000			"HPA049778: AB_2680877"	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		2.1	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.3	0.1	0.0	0.1	0.1	0.4	0.2	57.5	0.1	0.1	0.1	0.1	0.0	2.9	0.1	0.3	1.1	16.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	1.3	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.4	0.9	0.0	1.7	1.4	2.3	1.2	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	8.0	1.2	8.0	0.0	30.0	5.3	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.7	0.0	1.2	0.0	2.0	0.8	0.1	4.5	0.5	0.0	0.1	12.9	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.8	4.0	0.9	3.4	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838989-1841680	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 635.0;tongue: 527.7"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.7;hTCEpi: 65.2"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.4;granulocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		29000	29000	"Plasma membrane"	"Plasma membrane"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	13.9	0.1	0.1	0.1	0.1	0.5	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	16.5	11.6	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.3	0.0	1.2	0.1	0.0	15.7	0.4	635.0	4.8	0.2	0.1	0.2	0.4	0.1	0.1	0.0	0.0	3.0	527.7	11.5	2.1	0.1	2.3	46.4	26.7	8.6	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	22.7	0.6	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.4	65.2	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.4	0.0	0.6	0.0	0.6	0.0	0.4	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	6.1	3.1	26.7	0.0	6.5	0.0	1.9	0.0	0.0	4.3	2.3	0.0	0.0	21.1	0.2	8.6	46.4	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2"	"Group enriched"	"Detected in some"	11	"BEWO: 4.6;HSkMC: 6.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017861			Supported	Cytosol				Cytosol	Cytosol	"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.9	0.0	0.3	48.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.2	62.5	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.2	23.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.2	2.9	0.0	0.7	1.8	0.0	0.0	0.4	2.0	0.2	0.3	0.3	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	8	"NB-4: 6.1;NTERA-2: 16.5;SK-MEL-30: 7.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdTCR: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.2"	HPA011268	Enhanced				"Intracellular and membrane"	45000000	45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.1	16.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		100000000	100000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593119-121630295	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 3.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.8"	"Low region specificity"	"Detected in many"														"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	1.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	1.3	2.3	0.0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	38.0	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.5	0.4	0.0	0.0	0.0	3.0	1.9	0.8	0.2	0.1	0.0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.5	0.2	0.0
JSRP1	"FLJ32416, JP-45"	ENSG00000167476	"Junctional sarcoplasmic reticulum protein 1"	Q96MG2	19	2252252-2269759	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 92.0;tongue: 33.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 35.0;RPMI-8226: 21.9;U-266/70: 95.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 4.8"	"Group enriched"	"Detected in many"	6	"amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9"					HPA044741	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA044741: AB_10794295"	"unprognostic (9.41e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.64e-5)"	"unprognostic (3.63e-1)"	"unprognostic (4.43e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.71e-1)"	1.1	0.1	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.4	3.0	0.0	0.0	0.9	0.1	4.5	1.7	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	2.7	0.0	92.0	0.0	0.6	0.0	0.0	1.4	0.6	0.3	0.0	0.0	1.8	33.9	5.0	0.6	0.1	4.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	21.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	11.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.5	0.3	0.8	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371391-30372257	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"intestine: 5.9;skin 1: 14.9;tongue: 19.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	1300000	1300000												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		60000000	60000000	Nucleoplasm	Nucleoplasm	"HPA043801: , HPA050314: AB_2732558, HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell line enriched"	"Detected in some"	14	"SiHa: 49.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"																							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	49.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;HMC-1: 3.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"					"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.2	0.1	0.6	0.5	6.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437757-47449178	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enriched"	"Detected in some"	4	"RH-30: 71.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	"Plasma membrane, Centrosome, Cytosol"	"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	2.7	0.7	0.1	0.1	1.4	0.4	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.4	0.0	0.3	0.8	0.0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0.0	0.0	0.2	0.1	2.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.7	0.0	2.6	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.7	0.0	0.3	0.1
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin, alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 1935.3;tongue: 523.6"	"Cell line enriched"	"Detected in some"	22	"BEWO: 102.2"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000045, HPA041264, HPA041271"	Enhanced					6100000000	6100000000			"CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: "	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0.0	0.8	0.2	0.2	48.6	30.0	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.0	2.7	0.2	0.0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0.0	0.0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0.0	0.0	0.0	0.0	0.0	0.0	102.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.0	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5.0	7.7	12.1	5.1	14.0	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	15.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"heart muscle: 20.1;skeletal muscle: 52.0;tongue: 28.1"	"Cell line enhanced"	"Detected in single"		"A549: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	20.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	52.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	28.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT76	"HUMCYT2A, KRT2B, KRT2P"	ENSG00000185069	"Keratin 76"	Q01546	12	52768155-52777345	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"tongue: 81.4"	"Cell line enhanced"	"Detected in single"		"HaCaT: 2.4"	"Cancer enriched"	"Detected in single"	12	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019696	Approved					430000000	430000000			"HPA019696: AB_1852243"		"unprognostic (2.00e-1)"				"unprognostic (1.89e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	7.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Enhanced	Cytosol				Cytosol	Cytosol	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.8	3.1	0.1	1.3	0.9	0.6	0.5	2.2	1.8	1.2	1.9	0.3	0.7	0.8	0.9	1.2	0.6	0.8	0.8	12.3	2.2	1.3	1.2	0.6	2.2	3.7	0.8	0.8	0.7	0.9	2.8	0.4	1.0	1.0	3.6	0.6	0.9	0.4	0.2	0.6	2.4	1.4	2.6	1.4	2.2	1.1	1.5	0.4	0.5	0.5	2.8	1.0	0.8	1.0	0.8	1.7	1.1	0.8	0.8	0.8	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719673	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"skeletal muscle: 23.1;tongue: 13.0"	"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 102.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041691			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041691: "						"unprognostic (2.65e-2)"												0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 12.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced									"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced									"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.7;LHCN-M2: 8.7;RH-30: 22.6;U-266/70: 14.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.3	0.2	4.7	0.2	1.0	0.1	0.0	0.1	0.0	0.3	0.5	8.7	0.2	0.1	0.4	0.2	0.3	0.3	22.6	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.2	1.9	0.1	0.2	0.3	0.2	0.1	14.1	1.2	0.2	0.2	0.3	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ASB11	DKFZp779E2460	ENSG00000165192	"Ankyrin repeat and SOCS box containing 11"	Q8WXH4	X	15281697-15315656	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.6"	"Cancer enriched"	"Detected in single"	20	"melanoma: 2.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0"	"Low region specificity"	"Detected in single"														"unprognostic (5.89e-3)"				"unprognostic (1.04e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.54e-2)"		"unprognostic (2.04e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"		"unprognostic (6.21e-2)"		2.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.2	1.3	0.1	0.0	51.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	5.0	2.2	0.0	50.7	0.5	0.1	0.0	0.1	0.1	2.8	0.1	0.0	0.0	0.3	29.8	2.3	0.1	0.1	0.6	0.6	0.8	0.3	1.4	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.4	0.4	0.3	0.1	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	0.8	1.4	0.1	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP1B4		ENSG00000101892	"ATPase Na+/K+ transporting family member beta 4"	Q9UN42	X	120362085-120383249	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skeletal muscle: 47.3;tongue: 26.1"	"Cell line enriched"	"Detected in single"	4	"HSkMC: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (2.59e-2)"	"unprognostic (6.02e-4)"						"unprognostic (5.78e-1)"		"unprognostic (5.29e-2)"				1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.2	1.7	0.1	0.0	2.4	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.0	47.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	26.1	2.5	0.0	0.0	0.7	0.2	1.4	0.3	0.7	0.3	1.0	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.0	0.6	0.0	0.6	0.5	0.4	0.3	0.2	0.0	0.0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DLX3		ENSG00000064195	"Distal-less homeobox 3"	O60479	17	49990005-49995224	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"placenta: 47.6;skin 1: 32.4;tongue: 11.9"	"Group enriched"	"Detected in some"	5	"BEWO: 53.5;SK-BR-3: 17.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.44e-5)"	"unprognostic (3.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	0.5	0.2	0.1	0.0	0.1	0.0	1.5	0.0	0.2	2.2	0.3	0.1	0.0	0.0	0.1	0.6	2.8	0.1	0.2	0.1	0.1	0.1	0.5	0.0	0.4	0.0	0.0	0.0	1.4	0.8	0.0	0.2	47.6	0.3	0.7	0.0	0.5	1.1	1.1	0.1	32.4	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.4	3.6	11.9	3.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	1.0	0.3	0.2	53.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.6	6.6	2.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.2	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.7	5.9	0.0	0.6	17.2	0.0	6.8	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0
FHL3	SLIM2	ENSG00000183386	"Four and a half LIM domains 3"	Q13643	1	37996770-38005606	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"blood: 67.9;skeletal muscle: 247.1;tongue: 100.1"	"Cell line enhanced"	"Detected in many"		"HEL: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 67.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045723			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045723: AB_10966278"	"prognostic favourable (5.62e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.59e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavourable (4.20e-11)"	"unprognostic (8.88e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.77e-2)"	7.0	2.0	1.2	3.3	2.1	3.9	4.5	0.6	1.4	5.5	6.4	1.3	2.4	1.1	7.5	8.1	6.9	4.4	3.6	2.3	1.6	1.1	1.7	1.3	2.9	5.0	2.4	0.9	7.6	2.0	1.4	1.1	2.1	2.1	4.8	1.6	2.2	5.5	3.6	247.1	2.6	1.9	12.0	2.2	2.5	2.7	1.7	1.0	0.3	1.8	100.1	4.0	15.5	5.7	0.1	3.8	67.9	5.7	3.0	3.4	2.3	6.2	2.3	6.2	6.3	5.8	23.5	3.9	5.0	9.8	9.4	7.0	5.2	5.0	0.0	8.4	11.2	2.4	4.0	6.0	4.7	2.3	7.2	29.5	5.1	5.9	22.7	2.3	21.6	20.7	6.9	10.7	6.1	13.2	24.7	0.1	17.6	3.3	0.8	10.0	8.1	1.6	4.0	5.2	0.4	6.2	1.1	0.7	3.2	4.5	0.4	7.1	1.9	2.0	9.3	4.1	9.5	1.1	4.5	1.6	5.7	0.7	1.9	13.7	4.3	1.3	5.7	67.9	3.2	3.7	3.4	0.0	0.7	1.6	3.8	0.1	0.5	0.7	7.4	3.0	2.4	0.1	1.6	2.3	1.2	2.1	0.6	1.3	1.6	1.1	2.4	0.9	2.1	1.0
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721845	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HaCaT: 1.9;MCF7: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	1.9	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.4	0.1	5.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.5	0.0	0.1	0.1	0.0	2.4	0.1	0.2	89.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	1.8	0.1	56.1	24.8	0.1	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.8	0.4	0.1	0.0	0.1	1.9	0.0	0.2	0.1	0.0	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.5	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
RTN2	"NSP2, NSPL1, SPG12"	ENSG00000125744	"Reticulon 2"	O75298	19	45485289-45497061	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"skeletal muscle: 155.7;tongue: 43.2"	"Cell line enhanced"	"Detected in many"		"RH-30: 23.2;RT4: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034941, HPA034948"	Approved		Approved	"Nuclear speckles"		16000	16000	"Nuclear speckles"	"Nuclear speckles"	"HPA034941: , HPA034948: AB_2674375"	"unprognostic (3.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.68e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (4.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.03e-1)"	3.4	3.1	6.9	1.9	9.0	1.3	3.4	5.9	10.4	2.5	4.2	1.0	3.7	1.8	3.4	6.7	5.4	2.0	3.5	5.4	7.4	4.8	1.4	1.7	2.6	2.2	4.8	3.7	1.0	2.5	2.2	1.6	11.4	4.6	5.1	1.6	2.6	6.5	4.8	155.7	2.6	1.8	3.3	1.4	2.6	1.9	1.2	1.0	0.0	1.8	43.2	3.5	4.2	1.5	0.1	2.4	9.1	0.5	0.3	0.0	0.5	1.9	2.6	4.5	3.5	7.8	9.6	8.9	4.4	10.5	2.7	5.3	5.3	1.7	1.7	6.1	4.7	3.7	2.9	2.1	0.8	4.0	4.3	11.6	1.9	3.9	3.4	0.7	13.2	10.5	1.1	1.2	2.2	5.0	6.3	3.2	8.1	1.5	0.0	2.1	3.3	3.4	2.0	23.2	9.3	1.5	23.0	12.7	12.2	0.9	21.4	6.7	16.8	4.6	4.4	7.8	2.4	0.2	0.9	1.8	4.3	3.8	2.1	2.7	3.9	9.1	0.2	3.5	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.5	2.4	0.0	0.5	6.9	9.0	5.9	10.4	7.4	4.8	4.8	3.7	4.6	1.0
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA044002, HPA062229"	Enhanced									"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.4	0.0	0.7	0.0	1.4	1.5	0.3	0.8	0.3	0.0	1.8	0.5	0.1	0.1	0.0	0.0	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.1	0.2	0.5	0.3	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0
SYPL2	Mg29	ENSG00000143028	"Synaptophysin like 2"	Q5VXT5	1	109466628-109482137	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 102.5;tongue: 25.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076657			Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA076657: "	"unprognostic (1.82e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.90e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (3.05e-4)"	"unprognostic (2.54e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.39e-4)"	0.9	3.9	0.8	0.3	0.7	0.1	1.4	0.5	1.2	1.6	1.9	0.3	0.8	0.3	2.5	4.3	1.6	0.4	1.1	7.4	0.8	0.2	6.0	4.7	0.6	0.3	0.3	0.0	1.1	3.2	3.7	0.4	1.2	0.8	1.2	0.5	1.7	1.6	2.2	102.5	0.2	0.6	3.5	0.1	0.4	1.1	6.0	0.2	0.0	5.1	25.6	1.2	2.5	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	19.8	8.3	0.0	8.4	26.7	2.6	1.0	0.0	0.0	0.0	0.0	13.8	0.0	7.1	0.0	0.5	0.0	3.1	0.0	0.2	0.1	0.4	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	2.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.5	1.2	0.8	0.2	0.3	0.0	0.8	0.2
YIPF7	"FinGER9, FLJ39576"	ENSG00000177752	"Yip1 domain family member 7"	Q8N8F6	4	44622065-44678556	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 45.3;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;fHDF/TERT166: 1.4;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 0.7"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.8"	HPA030642	Uncertain									"HPA030642: AB_10601027"	"unprognostic (9.41e-4)"	"unprognostic (2.27e-1)"		"unprognostic (2.90e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.34e-1)"	"unprognostic (9.46e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.98e-2)"	1.5	0.0	0.3	0.0	0.5	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.6	0.1	45.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	14.8	0.7	0.0	0.0	2.3	3.3	0.3	1.0	0.3	0.9	0.3	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.3	0.0	0.7	0.0	0.6	0.3	0.0	0.3	0.5	1.1	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.5	0.7	0.4	2.3	0.9	0.7	0.6	0.6	0.3	0.4	0.3	0.3	0.2	3.3	0.1	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.3	0.0	0.1	0.0
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316126-143352083	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 38.9;tongue: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;HSkMC: 5.4;NTERA-2: 1.2;PC-3: 3.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	38.9	0.0	0.8	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.7	21.1	0.9	0.1	0.0	0.0	1.8	0.5	3.8	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA012513, HPA055286, HPA077371"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA012513: AB_1848446, HPA055286: AB_2682772, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.2	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	5.0	1.2	0.0	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0
FGF6		ENSG00000111241	"Fibroblast growth factor 6"	P10767	12	4428155-4445614	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 24.6;tongue: 6.9"	"Group enriched"	"Detected in some"	7	"NB-4: 1.7;NTERA-2: 6.0;REH: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"																				"unprognostic (4.29e-2)"			0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.0	0.0	6.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Group enriched"	"Detected in some"	30	"HaCaT: 94.2;SK-BR-3: 38.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		540000000	540000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP13-1	KAP13.1	ENSG00000198390	"Keratin associated protein 13-1"	Q8IUC0	21	30396074-30396822	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"skin 1: 13.0;tongue: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	2000000	2000000																					0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE2A	LEP9	ENSG00000187173	"Late cornified envelope 2A"	Q5TA79	1	152698364-152699442	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skin 1: 54.2;tongue: 14.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.8;SK-MEL-30: 3.8;U-138 MG: 1.9;U-2197: 2.7;U-87 MG: 1.3"	"Cancer enriched"	"Detected in some"	5	"melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (3.45e-2)"			"unprognostic (6.77e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	54.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR5		ENSG00000283227	"Small proline rich protein 5"	A0A1B0GTR4	1	152947154-152949258	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"skin 1: 30.7;tongue: 32.7"	"Group enriched"	"Detected in some"	8	"HaCaT: 4.0;hTCEpi: 10.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					14000000	14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC131097.2		ENSG00000216921			2	241893985-241902551	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"pancreas: 27.6;tongue: 59.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.9;REH: 6.5;SCLC-21H: 4.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073342			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	2.7	0.3	4.9	0.6	4.4	0.2	1.6	1.7	2.4	0.8	0.6	0.6	0.6	0.1	0.6	0.6	3.8	0.5	0.9	0.6	2.1	2.3	0.6	0.6	0.6	0.6	3.9	0.6	1.4	27.6	0.0	0.6	0.6	0.6	2.6	0.0	0.6	4.4	4.0	3.7	2.6	0.6	0.6	0.6	0.6	0.1	0.8	0.6	1.1	6.4	59.2	2.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.9	1.5	0.2	0.5	0.0	6.5	0.0	0.6	0.0	0.0	4.2	0.2	0.0	0.6	0.0	0.0	1.0	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.4	1.7	2.4	2.1	2.3	3.9	0.6	0.6	0.6
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 31.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.3	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.4	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.2	0.8	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3
IGFL2	UNQ645	ENSG00000204866	"IGF like family member 2"	Q6UWQ7	19	46143106-46161299	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 26.8;tongue: 24.8"	"Cell line enriched"	"Detected in single"	42	"CACO-2: 42.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"memory CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"									HPA059137	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA059137: AB_2683920"	"unprognostic (1.53e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.26e-3)"	"unprognostic (9.63e-3)"	"unprognostic (4.14e-9)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.91e-3)"	1.5	0.0	0.4	0.1	0.1	0.0	1.8	0.1	0.4	0.3	0.3	0.1	0.1	0.0	0.1	0.5	1.0	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.8	1.2	0.4	0.1	0.1	0.1	3.4	0.1	1.6	0.9	0.1	0.7	0.1	0.5	0.1	0.1	26.8	0.1	0.1	0.3	0.1	0.0	2.4	0.1	0.4	0.1	24.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.9	0.1
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.8;RT4: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 3.1;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 14.9"												"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.6	0.5	2.1	1.2	2.7	0.6	0.5	2.6	2.6	0.4	1.5	0.8	1.0	1.1	0.7	1.3	1.4	1.2	1.1	13.1	2.2	0.7	1.1	0.4	0.5	0.5	0.7	2.2	0.5	3.7	0.4	0.5	0.5	1.6	0.8	1.5	1.4	1.7	0.8	44.5	0.7	1.0	1.0	0.5	0.4	1.9	0.9	1.2	0.0	0.4	16.6	0.7	1.0	0.4	0.3	0.4	3.1	0.3	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.1	0.6	0.2	0.2	0.0	0.1	0.1	1.8	2.4	0.5	0.2	0.2	0.1	0.0	0.3	0.1	0.6	0.3	0.2	0.5	0.1	0.4	0.3	0.0	0.2	0.0	0.3	3.1	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	1.5	0.2	0.1	0.4	0.0	0.0	2.1	2.7	2.6	2.6	2.2	0.7	0.7	2.2	1.6	1.2
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 15.9;tongue: 58.7"	"Group enriched"	"Detected in some"	6	"HaCaT: 13.3;HMC-1: 8.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									350000000	350000000				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	58.7	0.9	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7"	"Group enriched"	"Detected in some"	6	"A549: 5.0;Hep G2: 19.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		680000	680000	Vesicles	Vesicles	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favourable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	6.3	2.7	0.2	0.0	59.5	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.7	0.0	104.6	0.4	1.5	0.0	0.0	0.0	0.0	1.9	0.1	0.0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	2.1	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	19.3	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0.0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970666-152972574	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"skin 1: 51.9;tongue: 18.9"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.5;hTCEpi: 2.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055963	Enhanced									"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.1	0.0	0.1	0.7	0.1	0.0	4.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.4	0.1	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	51.9	0.1	0.1	0.1	0.1	0.0	2.9	0.1	1.8	0.1	18.9	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 28.8;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;THP-1: 4.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA028375	Uncertain									"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.4	0.2	0.2	0.2	0.0	1.7	0.2	0.6	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.7	0.2	0.2	28.8	0.3	0.2	0.2	4.7	0.0	1.9	0.2	0.6	0.2	40.9	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.4	0.6	0.0	1.6	0.1	8.0	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	2.1	0.2	0.3	2.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.4	0.7	0.0	0.6	4.3	0.1	0.2	2.0	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.2
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847263-151853697	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skin 1: 59.8;tongue: 24.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 20.0"												"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.1	0.6	0.3	0.5	0.2	0.0	1.8	0.2	1.6	3.6	0.1	0.2	0.1	0.3	0.8	0.1	4.4	0.1	1.0	1.1	0.3	0.2	0.3	0.2	0.3	1.9	0.2	0.8	0.1	0.3	0.0	0.2	5.8	0.1	0.1	0.0	0.1	1.5	0.1	0.2	59.8	0.1	0.1	0.3	0.1	0.5	0.3	0.1	0.4	0.1	24.7	1.7	0.6	1.1	0.0	0.5	0.5	0.2	0.0	4.2	5.6	4.3	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.6	0.0	0.0	0.0	38.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.2	0.1	0.0	4.6	0.3	0.0	0.2	0.5	0.0	0.0	0.3	0.1	5.9	1.4	0.8	1.0	1.4	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.8	0.2	4.2	0.0	1.6	1.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.5	1.9	5.6	0.3	0.2	0.2	1.3	0.3	0.2	0.2	0.8	0.1	0.1
AC243967.1		ENSG00000267881			19	41708612-41761282	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"esophagus: 79.7;intestine: 34.3;lymphoid tissue: 77.4;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HaCaT: 1.8;MCF7: 1.9;RT4: 4.1;U-2 OS: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA011041	Approved									"HPA011041: AB_1078481"			"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.4	0.3	0.3	60.6	0.4	0.2	0.5	0.6	0.4	9.2	34.3	0.0	0.0	0.5	0.3	0.1	79.7	0.3	0.5	0.5	0.4	0.3	0.4	0.7	1.4	0.1	0.3	0.0	0.5	0.6	0.3	0.5	0.1	0.0	0.5	0.4	0.0	0.7	0.1	0.4	0.5	6.1	0.7	0.3	0.6	0.8	0.6	0.0	0.0	0.4	22.3	77.4	1.0	8.0	0.1	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.0	0.0	0.0
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333629	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"esophagus: 14.3;skin 1: 38.2;tongue: 17.3"	"Group enriched"	"Detected in some"	7	"MCF7: 2.2;T-47d: 7.9"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	2.2	0.1	0.1	3.8	0.1	0.1	0.1	0.0	0.4	0.1	14.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.1	1.4	0.1	0.2	38.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	17.3	3.5	0.1	2.2	0.6	0.4	0.4	0.2	1.0	3.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	7.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.0	3.6	0.1	3.5	1.6	0.0	0.6	2.3	2.3	0.4	1.0	0.2	0.4	2.0	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 39.0;RH-30: 49.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	33000000	33000000			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.0	0.1	0.0	0.0	0.9	0.0	1.4	10.0	0.4	0.2	0.0	0.0	2.3	0.4	1.0	0.8	0.2	0.1	0.2	0.9	0.0	37.1	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.0	39.0	0.8	0.6	0.1	0.0	0.4	0.5	0.0	0.2	49.4	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	0.6	0.9	0.2	0.1	0.2	8.5	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0
ASB14	DKFZp313L0121	ENSG00000239388	"Ankyrin repeat and SOCS box containing 14"	A6NK59	3	57268347-57292682	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"skeletal muscle: 26.3;tongue: 33.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.14e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.14e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.81e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.71e-3)"	0.7	0.4	0.3	0.6	0.3	1.9	0.7	0.6	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.6	0.5	0.5	0.3	5.0	0.3	0.3	0.3	0.3	0.6	0.7	0.3	0.3	0.7	2.3	0.0	0.3	0.3	0.3	0.3	0.0	0.6	0.8	0.3	26.3	1.0	0.6	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.8	33.6	1.3	0.3	0.7	2.4	1.6	0.0	0.5	0.5	0.6	0.1	0.8	0.4	0.6	1.2	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.7	2.3	2.9	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.8	1.4	2.8	0.3	0.0	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.4	2.3	3.0	0.6	1.1	0.4	0.8	0.6	0.0	2.0	0.8	2.6	0.6	1.1	0.3	1.0	0.5	1.0	0.5	0.8	2.4	2.0	1.5	1.7	1.3	2.3	1.7	0.8	0.0	0.5	0.0	0.2	0.1	0.2	0.7	0.3	0.0	0.4	2.4	0.6	0.6	0.0	0.5	0.2	1.6	0.0	0.1	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 45.1"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
DYNAP	"C18orf26, FLJ39106"	ENSG00000178690	"Dynactin associated protein"	Q8N1N2	18	54587757-54599493	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 23.9;tongue: 50.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 16.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA011148	Uncertain									"HPA011148: AB_1845609"		"unprognostic (9.88e-2)"		"unprognostic (2.51e-2)"		"unprognostic (1.75e-3)"				"unprognostic (1.45e-1)"					"unprognostic (8.09e-3)"			0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.8	0.1	0.1	0.1	0.1	0.5	1.4	23.9	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.1	0.4	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	2.1	0.1	0.2	0.5	0.2	0.3	0.1	1.4	0.2	0.4	0.1	0.2	0.1	50.3	6.7	0.1	0.3	1.8	1.0	3.1	2.9	0.7	1.0	0.0	1.0	0.3	1.7	0.8	0.9	2.0	1.7	0.4	0.7	1.3	1.3	0.9	0.6	0.9	0.6	0.9	0.6	1.2	0.0	0.7	0.3	0.3	0.3	1.1	0.6	0.7	0.8	0.8	0.8	0.2	1.3	0.4	0.3	1.3	16.5	0.2	0.3	0.6	0.5	2.6	0.5	0.6	2.0	0.8	0.5	0.9	0.7	1.0	0.3	0.3	2.9	0.5	1.1	2.8	0.6	3.2	0.6	0.5	0.6	0.4	1.3	0.9	0.4	0.4	1.2	1.3	2.1	1.0	1.1	0.7	1.0	0.6	0.4	0.4	1.8	0.7	0.7	3.1	0.7	2.9	1.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24131275-24132849	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9"	"Cell line enriched"	"Detected in some"	17	"RH-30: 26.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019842	Uncertain									"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	0.8	1.7	0.0	0.2	0.0	0.6	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0.0	0.0	0.2	13.1	0.2	0.3	0.0	0.0	0.2	11.9	0.2	0.2	0.2	0.0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0.0	2.5	0.3	0.3	0.0	0.0	0.5	79.9	3.6	0.3	0.0	0.8	0.3	0.0	1.1	0.4	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.5	0.1	0.0	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.3	0.2	26.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0.0	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	37	"Karpas-707: 7.2;U-266/84: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"					"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
KLK5	"KLK-L2, SCTE"	ENSG00000167754	"Kallikrein related peptidase 5"	Q9Y337	19	50943303-50953093	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 69.2;tongue: 67.3"	"Group enriched"	"Detected in some"	40	"A-431: 85.3;HaCaT: 83.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014343, CAB025503, CAB026341"	Enhanced				"Secreted in other tissues"					"CAB025503: , CAB026341: , HPA014343: AB_1852603"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"		"prognostic unfavourable (2.33e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.01e-1)"		"prognostic unfavourable (9.79e-4)"	"unprognostic (3.04e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-3)"	"unprognostic (2.21e-1)"		"unprognostic (2.76e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.16e-3)"	"prognostic unfavourable (3.85e-6)"	1.1	0.0	0.7	0.4	0.2	0.0	12.1	0.2	0.5	3.8	0.3	0.2	0.2	0.1	1.4	0.9	6.5	0.2	0.3	0.2	0.2	0.1	0.6	0.2	2.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	7.0	0.2	0.4	69.2	0.2	0.2	0.2	0.2	0.0	3.3	0.2	0.4	0.3	67.3	4.4	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	83.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.2
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 259.8;HBEC3-KT: 128.1;hTCEpi: 160.3;hTERT-HME1: 52.4;U-2197: 45.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		2200000000	2200000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favourable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	128.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	160.3	0.1	52.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LCE3C	"LEP15, SPRL3A"	ENSG00000244057	"Late cornified envelope 3C"	Q5T5A8	1	152600662-152601086	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"lymphoid tissue: 24.2;tongue: 17.3"	"Group enriched"	"Detected in some"	31	"hTCEpi: 1.3;hTERT-HME1: 4.7"	"Group enriched"	"Detected in some"	31	"head and neck cancer: 3.8;melanoma: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	17.3	24.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-87 MG: 2.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"	20000000	20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191511-195353	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 28.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	30.6	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.9	0.4	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	14.3	0.7	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	7.0	28.5	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.3	0.2	0.0	0.5	0.0
LRRC39	MGC14816	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148449-100178273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 30.7;skeletal muscle: 113.7;tongue: 28.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077159	Enhanced									"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	1.8	3.2	1.6	0.4	1.3	0.4	0.5	0.6	3.0	0.2	0.3	0.5	0.0	0.3	0.4	2.6	1.3	0.3	0.4	30.7	0.8	0.5	0.3	0.5	0.3	0.6	0.8	1.3	0.3	0.3	0.3	0.5	1.3	0.5	1.3	0.3	9.5	1.1	0.3	113.7	1.1	0.3	0.3	0.7	0.5	0.3	1.7	0.6	0.1	0.5	28.5	1.2	0.3	0.1	1.1	0.4	0.2	0.6	0.2	0.9	0.0	0.6	0.9	3.0	4.2	0.7	1.8	2.5	1.3	0.6	0.6	1.4	0.2	1.8	3.3	1.4	0.6	1.9	0.3	0.4	1.3	0.4	2.8	1.4	3.1	0.6	0.5	1.0	1.8	3.2	0.7	0.7	0.3	0.7	1.4	2.9	1.1	0.6	1.7	4.0	1.3	1.1	1.5	1.4	1.3	0.6	1.0	1.3	4.2	1.0	1.1	11.8	1.0	2.2	0.9	1.6	1.6	2.4	2.7	5.6	2.8	1.0	3.1	2.1	0.4	0.0	0.4	0.2	0.4	0.6	0.6	0.9	0.4	0.4	0.1	1.1	0.9	0.9	0.2	0.2	0.3	0.4	0.4	0.0	1.6	1.3	0.6	3.0	0.8	0.5	0.8	1.3	0.5	0.6
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"					"Low region specificity"	"Detected in all"														"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.5	0.0	0.8	1.0	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9"	"Group enriched"	"Detected in some"	18	"EFO-21: 14.8;HaCaT: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"non-classical monocyte: 76.5"	"Lineage enriched"	"Detected in many"	20	"monocytes: 76.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028599	Uncertain				"Intracellular and membrane"					"HPA028599: AB_10603777"		"prognostic favourable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favourable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.3	0.0	77.5	0.2	0.1	1.2	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	7.7	0.0	0.5	6.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	5.7	0.0	37.9	69.2	0.0	10.1	0.2	3.7	0.0	76.5	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	76.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	1.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3220108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6"	"Group enriched"	"Detected in some"	9	"HAP1: 16.2;HMC-1: 4.4;HSkMC: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					32000	32000			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	6.2	0.6	1.3	0.9	1.2	0.3	0.8	0.6	0.7	1.0	2.4	0.3	0.4	0.5	2.9	10.1	6.0	1.3	3.0	111.4	1.1	1.3	0.4	16.6	0.4	0.4	2.2	0.1	0.9	6.4	0.3	0.3	0.5	0.9	2.6	0.7	3.4	4.6	1.1	153.1	0.3	0.9	9.3	2.0	0.3	0.7	1.2	0.1	0.0	1.6	51.6	4.6	5.0	0.5	0.7	3.0	0.6	0.4	0.8	2.1	1.1	0.0	0.1	0.3	0.0	0.8	1.0	0.3	0.5	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.2	0.0	16.2	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	4.4	7.9	0.4	0.3	0.1	0.1	0.0	0.5	0.3	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.6	0.9	0.4	0.5	0.7	0.6	0.5	0.5	0.6	1.0	2.1	0.5	0.8	0.0	3.0	0.2	1.1	1.3	1.2	0.6	0.7	1.1	1.3	2.2	0.1	0.9	0.1
PHKG1	PHKG	ENSG00000164776	"Phosphorylase kinase catalytic subunit gamma 1"	Q16816	7	56080283-56092996	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 105.6;tongue: 32.9"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	18	"glioma: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012057	Enhanced									"HPA012057: AB_1855305"	"unprognostic (2.00e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.09e-3)"	"unprognostic (5.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.14e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.97e-9)"	"unprognostic (6.61e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.85e-2)"	2.0	1.5	4.9	0.8	6.1	1.1	1.5	6.0	5.8	0.7	2.6	6.5	0.0	1.0	0.9	1.5	3.2	0.9	1.1	11.8	4.1	2.9	0.6	0.7	0.9	0.8	3.5	3.9	1.0	0.8	1.2	0.6	0.6	6.8	1.4	0.8	0.0	1.6	0.8	105.6	1.6	0.9	1.1	3.6	0.8	0.8	0.7	4.8	0.0	0.6	32.9	1.2	1.8	0.3	1.3	0.6	3.3	0.7	0.3	1.9	0.2	2.9	2.1	0.5	1.7	3.1	5.3	1.4	0.3	0.6	1.0	0.8	0.7	1.3	0.8	0.5	1.0	1.5	1.2	0.2	0.8	0.8	2.1	0.8	2.9	0.7	0.8	1.5	3.2	3.3	2.2	1.6	0.7	0.3	2.2	3.9	0.1	1.3	2.2	5.5	1.0	1.3	1.2	0.3	1.0	0.6	1.9	1.5	1.6	0.3	2.1	0.1	1.1	1.9	0.8	0.5	1.7	4.4	1.1	1.8	0.7	2.2	1.2	1.4	1.0	0.4	0.5	0.0	0.8	0.2	1.9	0.3	1.2	0.3	0.2	1.3	0.6	0.6	3.3	0.3	0.7	0.6	0.5	0.2	4.9	6.1	6.0	5.8	4.1	2.9	3.5	3.9	6.8	4.8
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11 (gene/pseudogene)"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;BEWO: 2.0;hTCEpi: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"															"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	23.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	19.1	2.0	2.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0										
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		59000	59000	"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK9		ENSG00000204909	"Serine peptidase inhibitor, Kazal type 9"	Q5DT21	5	148321203-148339849	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"tongue: 65.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.2;U-266/84: 19.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			HPA038288	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038288: AB_10795400"	"unprognostic (1.84e-1)"	"unprognostic (4.87e-3)"			"unprognostic (2.88e-1)"	"unprognostic (9.02e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.90e-1)"	1.0	2.3	2.3	2.2	4.0	6.2	1.0	1.3	3.2	1.0	1.2	1.0	1.0	1.1	2.0	1.5	1.5	0.5	1.0	2.3	2.2	3.3	1.3	1.0	1.0	1.9	1.5	1.0	1.4	1.4	0.5	1.4	2.5	1.0	1.8	1.2	1.0	1.0	1.0	2.4	2.7	1.7	1.0	1.1	1.1	2.0	3.8	1.0	2.7	1.0	65.0	1.1	1.2	1.0	3.4	2.7	10.7	2.9	5.8	2.8	0.2	10.9	2.0	2.8	3.0	0.4	1.0	2.4	3.0	0.1	0.2	0.5	4.5	8.4	3.2	18.2	0.2	2.3	0.9	0.6	0.8	4.6	2.2	6.3	6.8	2.0	0.2	2.2	2.6	0.1	0.6	0.3	0.1	0.0	3.8	14.1	0.4	9.4	2.2	3.3	11.2	4.4	2.9	2.8	3.5	1.4	9.0	5.1	5.8	2.9	6.4	1.9	10.4	2.1	6.9	3.3	10.6	3.2	3.4	8.9	19.3	3.2	2.7	1.9	4.5	10.7	2.9	1.3	1.8	1.6	2.1	1.3	2.0	2.1	0.7	3.4	2.6	2.8	10.5	5.8	2.8	2.7	1.3	0.2	2.3	4.0	1.3	3.2	2.2	3.3	1.5	1.0	1.0	1.0
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.4	1.1	1.2	1.0	1.3	0.3	1.1	1.7	1.8	1.4	1.0	0.5	1.5	1.0	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1.0	1.1	1.5	6.8	0.8	2.8	1.9	1.0	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1.0	0.8	0.4	1.8	2.0	37.8	4.0	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.8	2.8	2.1	6.5	2.7	2.6	7.6	2.6	2.3	2.7	3.8	9.0	6.8	4.0	9.1	0.9	2.8	2.3	3.7	5.6	9.0	1.8	6.0	1.3	5.7	3.1	5.4	4.8	3.3	6.7	4.2	3.8	0.3	4.2	1.6	2.7	3.5	2.9	5.2	3.6	2.9	3.1	5.5	3.8	3.7	4.2	5.4	1.9	3.5	3.9	8.5	3.2	2.9	0.2	4.3	3.1	3.3	3.3	3.9	9.9	3.3	4.4	9.0	6.4	0.0	0.0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4
ADSSL1	FLJ38602	ENSG00000185100	"Adenylosuccinate synthase like 1"	Q8N142	14	104724186-104747325	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 200.5;tongue: 53.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;MCF7: 11.3;SiHa: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									220000	220000				"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	2.5	1.1	0.8	0.5	1.8	0.4	0.9	0.3	1.2	0.8	0.7	3.4	0.3	0.8	0.9	3.5	3.9	1.5	2.2	27.8	1.2	1.5	2.9	7.2	0.7	0.5	3.3	0.4	0.8	1.7	1.9	2.2	1.6	2.0	1.9	0.6	4.6	3.2	1.1	200.5	1.3	0.8	1.0	2.1	0.5	1.2	3.4	2.0	0.0	1.7	53.2	2.8	6.1	3.8	0.0	0.4	1.2	2.1	0.0	0.5	0.0	0.1	2.6	2.0	5.8	1.4	0.9	0.6	0.7	1.1	0.2	0.6	0.2	2.0	0.0	12.7	0.6	1.0	0.2	0.4	0.5	0.8	0.4	0.0	6.2	0.9	1.5	0.0	5.0	2.8	1.9	0.0	2.1	0.4	2.3	0.1	1.0	11.3	0.0	0.6	1.7	1.1	0.1	0.3	0.7	0.4	1.4	1.7	3.5	19.0	0.8	2.5	5.9	1.6	0.6	0.1	0.5	1.3	0.0	3.7	2.7	0.0	1.8	0.8	1.2	0.0	0.1	1.2	0.5	2.1	0.0	0.0	0.1	0.4	0.4	0.0	0.4	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.8	1.8	0.3	1.2	1.2	1.5	3.3	0.4	2.0	2.0
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		16000	16000	Nucleoplasm	Nucleoplasm	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224196-64230631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"skeletal muscle: 43.4;tongue: 11.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;HEK 293: 2.1;HL-60: 2.1;HMC-1: 2.7;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049542	Uncertain									"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.0	1.0	0.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.2	43.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.6	11.5	0.7	0.0	0.0	1.1	0.0	4.0	0.3	0.1	1.0	0.3	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.6	0.0	0.0	0.9	0.0	0.4	0.0	2.1	1.8	0.0	0.0	0.0	2.1	2.7	0.0	0.5	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.5	2.2	2.3	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.3	0.4	0.0	0.4	0.2	0.0	1.1	0.3	0.2	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFC	"BPIL2, dJ149A16.7"	ENSG00000184459	"BPI fold containing family C"	Q8NFQ6	22	32413847-32464484	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"skin 1: 39.5;tongue: 16.4"	"Group enriched"	"Detected in some"	5	"HDLM-2: 3.3;hTCEpi: 1.6;SCLC-21H: 4.6;U-87 MG: 2.3"	"Group enriched"	"Detected in some"	11	"head and neck cancer: 1.6;melanoma: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	56	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	56	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"							"unprognostic (2.74e-1)"			"unprognostic (3.48e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.80e-1)"			0.0	0.0	0.4	0.0	0.5	0.0	2.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	39.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	16.4	0.8	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299193-49327487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 104.2;tongue: 35.0"	"Group enriched"	"Detected in some"	21	"K-562: 8.9;RH-30: 13.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057556			Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	2.0	1.7	0.1	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	3.3	15.3	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	104.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.5	35.0	3.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306414-45322977	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 1374.7;tongue: 354.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 36.8"	"Group enriched"	"Detected in many"	33	"head and neck cancer: 64.4;prostate cancer: 14.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	25	"dendritic cells: 2.1;monocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047859	Enhanced					190000000	190000000			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0.0	0.0	11.1	354.9	24.8	0.2	0.1	0.0	2.1	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.9	0.0	0.1	8.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266858-56270966	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				Cytosol	Cytosol	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	2.9	12.4	5.0	2.3	6.8	2.2	3.1	7.6	7.3	3.7	2.9	4.8	5.9	1.9	3.6	7.7	4.3	5.2	3.2	43.5	4.5	5.4	7.2	12.8	3.5	3.4	5.6	3.9	4.5	5.5	6.0	9.9	1.7	4.8	4.1	2.7	14.0	6.5	5.6	103.7	2.2	2.9	3.7	3.6	3.8	2.6	2.4	3.0	4.9	5.4	46.1	6.2	2.7	3.3	11.7	6.8	8.0	1.1	5.0	8.6	3.6	2.4	10.2	9.9	6.4	5.7	5.7	4.2	3.5	8.5	12.6	12.6	7.9	3.8	14.6	8.1	8.9	2.3	11.4	2.0	7.5	2.2	12.7	6.8	9.3	8.2	7.8	5.3	4.1	5.9	3.3	9.3	3.7	6.6	4.5	6.0	11.6	3.3	7.6	19.1	8.4	5.9	16.4	10.8	9.6	6.9	1.5	14.3	15.5	12.2	2.5	3.8	3.9	5.9	4.6	2.4	7.0	6.7	3.6	12.6	13.5	7.1	7.0	5.0	1.8	8.0	1.0	0.9	7.7	1.1	7.9	11.7	7.1	8.2	1.7	6.7	8.6	8.4	0.4	5.0	0.8	6.8	4.6	3.6	5.0	6.8	7.6	7.3	4.5	5.4	5.6	3.9	4.8	3.0
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		2700000	2700000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB037328: , HPA049265: AB_2680695, HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		18000000	18000000	Cytosol	Cytosol	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364058-89386461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3"	"Group enriched"	"Detected in some"	9	"A-431: 7.8;HaCaT: 17.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;T-cells: 2.7"									HPA027744	Enhanced									"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	15.6	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	61.3	60.5	0.1	6.8	0.6	0.6	3.4	0.6	0.3	2.7	0.4	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.0	17.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.4	0.7	0.2	1.2	0.6	0.9	1.2	0.4	0.4	0.7	0.7	3.4	0.3	0.4	0.6	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
KLK9	KLK-L3	ENSG00000213022	"Kallikrein related peptidase 9"	Q9UKQ9	19	51003111-51009634	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 37.6"	"Group enriched"	"Detected in some"	27	"HaCaT: 1.2;HBEC3-KT: 4.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025049	Enhanced				"Secreted to digestive system"					"CAB025049: "						"unprognostic (3.22e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	37.6	3.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452126	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 135.3;tongue: 232.4"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 19.7;hTCEpi: 22.0;RPMI-8226: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1424.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB000130: , HPA045697: AB_2679422, HPA061168: "	"prognostic favourable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavourable (9.52e-4)"	0.2	0.1	0.1	0.5	0.1	0.1	3.9	0.1	0.1	33.3	0.1	0.1	0.1	0.1	0.7	0.1	135.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	17.8	0.1	0.1	34.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	232.4	15.4	0.1	26.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Group enriched"	"Detected in some"	6	"PC-3: 21.7;U-2 OS: 29.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.1"	"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		2200000000	2200000000	Cytosol	Cytosol	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.6;HEL: 6.1;LHCN-M2: 6.1;TIME: 4.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064844			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.0	0.2	0.3	1.0	2.2	0.1	0.8	1.5	0.5	0.8	0.0	0.2	0.3	0.2	10.6	0.2	3.7	0.0	1.4	0.5	0.1	6.1	0.4	0.2	0.2	0.2	0.1	0.2	0.1	4.3	0.0	0.2	0.1	0.4	6.1	0.1	0.8	0.1	1.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.7	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	1.0	0.4	1.5	0.5	1.0	0.2	4.2	1.1	0.9	0.2	0.4	1.1	1.8	0.4	0.7	0.2	0.1	0.1	1.6	0.3	0.1	0.4	2.3	1.5	0.5	0.1	0.3	1.3	0.2	0.7	0.4	0.7	0.5	2.2	0.3	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 17.7;SK-MEL-30: 17.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0.0	0.0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0.0	0.0	2.7	31.6	2.2	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	2.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	17.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.6	1.3	0.0	0.0	0.5	17.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0.0
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819764-126821786	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"heart muscle: 8.9;tongue: 26.7"	"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8"	"Low region specificity"	"Detected in many"			HPA048386	Uncertain									"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.1	3.4	0.0	8.9	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	1.7	0.0	3.1	0.1	0.0	0.3	0.5	0.3	0.0	0.0	0.1	0.0	0.0	26.7	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.9	0.1
RPTN	FLJ39117	ENSG00000215853	Repetin	Q6XPR3	1	152153595-152159228	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0"	"Group enriched"	"Detected in some"	7	"HaCaT: 3.6;hTCEpi: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA030483, HPA030485"	Enhanced				"Secreted to extracellular matrix"					"HPA030483: AB_2673495, HPA030485: AB_10601159"		"unprognostic (1.37e-2)"				"unprognostic (5.06e-2)"		"unprognostic (2.35e-1)"	"unprognostic (4.54e-2)"		"unprognostic (4.00e-2)"						"unprognostic (5.23e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	71.0	33.2	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		130000	130000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.7;HUVEC TERT2: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	290000	290000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.7	0.8	11.7	4.5	4.9	1.6	1.0	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.1	1.1	0.4	0.7	1.0	3.4	6.1	0.5	0.9	0.6	0.1	2.3	2.8	1.4	1.0	0.5	20.4	0.5	0.6	1.9	0.4	1.0	0.8	5.2	1.3	7.2	2.6	0.2	0.4	0.3	5.9	7.7	1.1	0.5	0.9	1.3	1.0	9.5	2.0	2.8	2.9	0.4	4.9	0.9	5.0	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Cell line enriched"	"Detected in some"	7	"U-937: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		42000	42000	Nucleoplasm	Nucleoplasm	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180952-23325165	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 37.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA007476	Enhanced									"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	8.6	0.1	0.1	0.2	0.1	0.0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0.0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	37.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.2	2.7	5.4	2.9	0.3	4.9	2.7	0.9	3.3	3.3	7.0	1.8	2.3	1.9	3.2	2.6	10.3	2.8	2.1	4.0	8.8	1.6	4.9	8.2	6.0	1.4	1.6	2.2	7.0	5.0	1.4	2.4	3.8	1.8	2.0	5.1	1.6	3.1	4.3	7.0	2.6	1.4	3.3	7.4	5.0	8.7	6.6	3.2	1.4	12.4	2.5	1.2	1.8	0.2	1.5	1.6	3.4	7.8	3.5	3.0	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR2A		ENSG00000241794	"Small proline rich protein 2A"	P35326	1	153056113-153057537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 393.4;lymphoid tissue: 173.5;tongue: 572.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.6;hTCEpi: 8.2;hTERT-HME1: 10.9;Karpas-707: 13.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 743.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.64e-2)"		"unprognostic (6.80e-3)"	"unprognostic (3.51e-1)"		"unprognostic (3.36e-3)"			"unprognostic (4.53e-2)"			"prognostic unfavourable (1.37e-5)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	82.8	0.2	0.0	0.0	0.2	3.0	0.2	393.4	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	58.3	0.2	0.2	1.3	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	572.8	173.5	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	10.9	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.3	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR2F		ENSG00000244094	"Small proline rich protein 2F"	Q96RM1	1	153112114-153113515	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"tongue: 310.0"	"Cell line enriched"	"Detected in single"	8	"K-562: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (7.40e-2)"		"unprognostic (1.14e-2)"		"unprognostic (1.48e-2)"		"unprognostic (2.41e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.57e-1)"				"unprognostic (2.54e-1)"	"unprognostic (2.96e-1)"		"unprognostic (1.78e-3)"	0.4	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	4.5	0.1	0.1	0.1	0.0	0.2	0.3	66.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	28.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.1	0.2	0.2	0.5	0.1	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	310.0	24.8	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.8;HaCaT: 17.6;HeLa: 11.5;MCF7: 12.6;SK-BR-3: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171"	Enhanced					430000	430000			"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	12.8	0.3	0.2	0.7	1.2	0.9	1.3	0.7	1.7	0.9	17.6	2.1	1.4	0.5	1.4	2.4	1.0	11.5	4.0	0.6	0.6	1.1	1.1	7.0	0.4	1.5	0.5	0.7	0.7	0.5	12.6	0.5	1.3	0.2	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.1	0.2	15.7	0.0	1.1	0.8	0.6	0.8	3.7	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 7.0;T-47d: 12.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.4	0.1	0.6	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.4	1.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.8	0.8	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.6	2.0	0.0	0.6	0.0	0.1	0.9	0.7	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	12.8	0.0	0.1	0.0	0.2	1.1	0.0	1.7	1.1	0.1	0.8	0.2	0.4	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079973-87029052	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 16.7;tongue: 35.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"																						"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.8	1.3	0.0	0.0	0.0	0.1		0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	1.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.5	1.0	0.0	0.0	0.5	0.3	1.3	0.3	0.3	0.2	0.0	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	1.8	0.1	0.0	0.2	2.8	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.7	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.3	0.3	0.0	0.3	0.1	0.0										
ALOX12B	12R-LOX	ENSG00000179477	"Arachidonate 12-lipoxygenase, 12R type"	O75342	17	8072636-8087703	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 38.9;tongue: 55.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HEK 293: 3.9;hTCEpi: 4.4;REH: 2.8;U-266/84: 2.8"	"Group enriched"	"Detected in many"	9	"cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024002	Supported		Approved	Cytosol				Cytosol	Cytosol	"HPA024002: AB_1844757"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.18e-2)"		"unprognostic (1.26e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.46e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	1.1	0.1	0.3	7.7	0.1	0.1	0.1	0.1	0.5	0.1	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.6	38.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	55.3	11.4	0.1	6.2	0.9	0.2	7.0	0.0	0.2	1.1	0.2	1.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.7	0.3	0.2	0.0	0.0	3.9	0.0	1.1	0.3	0.0	0.6	0.0	0.0	4.4	0.2	0.7	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.7	0.4	2.8	0.0	1.1	0.5	0.0	1.2	1.7	0.3	0.2	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.0	0.7	0.9	0.3	0.5	0.0	0.3	1.1	1.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033311: AB_781574, HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell line enhanced"	"Detected in many"		"AF22: 7.2;NTERA-2: 10.1;SCLC-21H: 15.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.2	2.7	1.6	2.4	5.2	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	0.3	3.4	0.1	2.1	1.7	2.4	0.0	1.1	0.0	0.5	0.3	0.4	5.8	0.3	1.0	0.6	1.2	0.2	0.3	4.5	0.1	2.0	0.3	10.1	0.8	2.9	6.8	0.0	0.8	0.4	15.5	4.1	0.2	0.3	1.4	0.2	0.2	1.3	1.8	1.4	1.3	1.1	0.4	1.3	0.7	1.9	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165564-30166756	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0"	"Group enriched"	"Detected in some"	15	"HaCaT: 2.2;hTCEpi: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced									"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	24.4	2.8	0.0	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7"	"Cell line enhanced"	"Detected in many"		"A549: 14.4;HEK 293: 20.7;MCF7: 9.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 25.1;naive B-cell: 27.5"	"Lineage enriched"	"Detected in many"	11	"B-cells: 27.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"				Microtubules	Microtubules	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favourable (4.02e-5)"	"unprognostic (2.45e-1)"	0.4	0.3	0.2	0.2	0.8	0.2	2.5	0.2	0.2	58.9	0.5	0.2	0.2	0.2	4.4	1.4	268.7	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.3	0.2	39.0	0.3	0.5	37.3	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.9	0.2	323.6	276.3	0.2	85.7	27.5	2.4	0.5	2.0	0.0	0.7	1.0	4.6	14.4	0.3	1.3	0.7	0.7	0.2	0.8	0.3	0.3	0.3	0.8	1.2	4.0	6.5	0.2	1.9	1.2	1.8	0.1	0.0	20.7	0.3	5.4	1.5	0.0	0.0	0.0	1.5	3.2	0.8	0.0	0.0	0.8	0.2	0.0	9.8	0.0	0.1	5.3	4.3	1.7	0.2	2.2	1.4	1.8	2.2	6.3	2.7	4.0	1.9	4.9	2.0	0.0	0.0	4.4	0.1	0.0	4.7	5.6	2.6	0.0	1.7	0.2	0.0	2.0	0.0	0.7	1.5	0.2	25.1	0.5	0.5	2.4	27.5	0.2	0.4	0.5	0.0	0.3	0.5	0.0	1.0	0.2	0.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912518-67696169	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.0;RPMI-8226: 3.9;SCLC-21H: 2.6;U-266/70: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.2;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced									"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	1.8	1.4	6.3	3.6	19.3	0.8	1.5	6.6	10.3	2.1	2.5	26.0	0.0	1.1	2.5	0.8	2.9	1.7	1.6	27.5	7.6	2.3	1.1	12.9	1.1	0.9	25.9	5.8	3.4	1.1	1.2	1.1	1.2	16.2	1.2	1.6	0.0	1.2	1.0	16.2	1.2	1.9	4.5	26.8	1.1	1.8	3.6	28.8	0.0	1.4	7.9	1.1	1.3	1.9	0.7	1.4	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	4.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.1	0.0	3.0	1.2	0.2	0.0	3.9	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	11.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	6.3	19.3	6.6	10.3	7.6	2.3	25.9	5.8	16.2	28.8
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.7;NTERA-2: 2.5"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021361-94113751	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 68.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HaCaT: 4.1;HBEC3-KT: 7.3"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	21	"olfactory region: 1.4"	"Not detected"	"Not detected"			HPA031517	Uncertain					51000000	51000000			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	68.0	16.2	0.0	4.8	1.1	0.3	0.1	0.0	0.9	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.3	0.0	4.1	0.0	7.3	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.3	1.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647901-53665708	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.5;RH-30: 2.8;SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	13.1	0.5	0.1	0.3	0.3	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.1	0.0	1.6	0.0	57.7	0.6	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	40.9	2.2	0.3	0.2	0.7	0.0	0.0	0.1	0.9	0.6	0.0	1.0	0.7	0.2	0.2	0.0	0.0	0.5	0.0	0.2	0.2	0.1	1.1	2.5	0.0	0.2	0.0	1.9	0.7	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0.0	2.1	2.5	0.0	0.5	0.0	0.0	0.2	0.0	0.8	0.8	0.0	0.3	0.7	0.1	2.8	0.1	0.8	0.9	3.6	0.3	0.2	0.6	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.2	0.5	0.1	0.0	0.3	2.1	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.6;HaCaT: 25.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	960000	960000	"Plasma membrane"	"Plasma membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.6	0.0	1.0	0.0	25.9	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 503.5"	"Cell line enriched"	"Detected in some"	9	"hTCEpi: 134.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		2200000000	2200000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	1.6	0.2	0.2	0.2	0.2	0.0	2.1	0.2	0.2	32.4	0.2	0.2	0.2	0.0	1.1	0.2	112.4	0.1	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.2	0.7	0.0	0.3	15.5	9.9	0.4	41.4	0.2	0.2	0.2	0.2	0.1	0.6	0.2	3.0	0.2	503.5	26.4	0.6	50.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	3.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	134.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	0.1	0.9	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		7200000000	7200000000	"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 166.3;lymphoid tissue: 128.7;tongue: 53.1"	"Group enriched"	"Detected in some"	7	"EFO-21: 9.7;RT4: 2.7;SK-BR-3: 6.8;U-87 MG: 5.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"					"Not detected"	"Not detected"			HPA039724	Enhanced					71000000	71000000			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	26.8	0.1	0.1	0.1	0.0	0.6	0.1	166.3	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	18.3	0.1	0.3	15.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	53.1	128.7	0.2	25.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.7	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43795929-43827206	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 39.6;skin 1: 39.8;tongue: 34.7"	"Cell line enhanced"	"Detected in some"		"A-431: 5.8;BEWO: 9.0;HaCaT: 9.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	4	"monocytes: 3.8;T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favourable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.5	1.2	3.4	2.1	7.9	0.7	4.2	2.4	8.8	5.7	1.4	3.5	0.5	1.2	1.3	2.4	7.8	1.6	1.9	1.3	3.9	4.8	0.9	1.0	3.4	1.4	4.5	4.0	0.8	0.9	1.1	1.4	39.6	9.3	1.3	1.5	0.7	2.1	1.5	0.7	39.8	1.1	1.9	3.3	5.9	1.3	7.4	2.7	0.6	1.4	34.7	3.4	2.4	5.4	0.4	0.0	0.5	3.8	0.0	1.2	0.5	5.8	0.0	0.3	0.0	0.1	0.0	9.0	0.4	0.0	0.8	1.0	0.6	2.0	0.3	1.1	0.7	9.3	0.0	1.0	0.5	1.0	0.0	0.2	0.6	0.0	2.5	0.1	0.1	2.8	2.6	0.4	1.1	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.6	1.9	0.0	0.1	0.1	0.6	0.9	0.7	0.2	1.2	1.4	0.0	0.6	0.2	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	1.2	0.0	0.0	3.8	0.3	0.0	0.8	0.1	0.0	0.4	0.4	1.2	0.5	0.0	1.4	0.0	0.0	0.5	3.4	7.9	2.4	8.8	3.9	4.8	4.5	4.0	9.3	2.7
MYBPC2	"MGC163408, MYBPC, MYBPCF"	ENSG00000086967	"Myosin binding protein C, fast type"	Q14324	19	50432903-50466321	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 311.8;tongue: 133.8"	"Group enriched"	"Detected in some"	17	"HDLM-2: 21.4;Karpas-707: 54.4"	"Cancer enriched"	"Detected in some"	9	"head and neck cancer: 9.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.5;naive B-cell: 3.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042991	Enhanced									"HPA042991: AB_2678257"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.15e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.38e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-8)"	"unprognostic (1.85e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.73e-1)"	9.6	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	42.6	1.6	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.2	50.3	0.1	0.0	0.0	0.5	0.0	0.0	4.5	0.0	311.8	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	1.3	133.8	4.0	0.1	0.1	3.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.5	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.0
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 33.1;tongue: 13.0"	"Group enriched"	"Detected in some"	4	"HaCaT: 6.2;K-562: 1.5;U-87 MG: 4.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027714	Approved									"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	1.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.3	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;HSkMC: 2.0;SiHa: 3.1;U-2197: 10.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048341, HPA049988, HPA055992"	Supported					5700000	5700000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SPRR2D		ENSG00000163216	"Small proline rich protein 2D"	P22532	1	153039725-153041931	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"esophagus: 246.4;tongue: 317.8"	"Group enriched"	"Detected in some"	5	"hTCEpi: 25.6;hTERT-HME1: 22.5;SK-MEL-30: 11.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 80.9;head and neck cancer: 353.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (7.50e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.17e-2)"		"unprognostic (5.14e-2)"		"unprognostic (1.49e-3)"	"unprognostic (3.58e-1)"		"unprognostic (1.37e-3)"			"unprognostic (6.85e-2)"	"unprognostic (1.90e-2)"		"prognostic unfavourable (1.62e-4)"	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.4	0.1	246.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	29.9	0.1	0.1	14.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	317.8	63.5	0.1	40.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	25.6	0.0	22.5	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.7	0.0	0.1	4.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"	"Nuclear membrane, Nucleoli"	"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919273	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 14.3;PC-3: 7.7;RPMI-8226: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.7	12.5	0.5	0.2	0.5	0.1	1.3	1.5	0.4	0.3	0.9	0.4	0.1	1.0	0.3	1.5	2.0	0.8	0.4	0.4	0.4	0.5	0.6	3.3	1.0	0.1	0.2	0.5	0.5	67.1	0.9	0.3	0.2	0.4	0.5	0.4	0.5	13.8	0.1	77.9	0.8	1.7	0.2	0.3	0.7	1.2	7.9	0.2	0.2	0.9	38.9	2.5	0.3	0.4	0.2	2.3	0.0	0.4	0.0	0.6	0.0	2.4	0.2	0.6	1.3	0.2	0.1	5.5	0.3	0.1	1.6	1.0	4.0	1.6	0.6	1.6	2.5	0.8	4.0	1.1	0.3	0.2	2.9	0.0	0.6	14.3	0.8	0.0	0.9	0.0	2.3	0.5	0.2	0.1	3.5	1.4	0.0	4.5	0.3	1.1	2.1	7.7	1.0	0.0	26.1	0.8	0.1	2.7	1.9	0.0	2.3	0.3	1.5	0.3	0.0	0.0	1.1	0.7	0.0	1.8	0.6	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.5	1.5	0.4	0.4	0.5	0.2	0.5	0.4	0.2
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052834	Uncertain				"Intracellular and membrane"					"HPA052834: AB_2681969"	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 96.9"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Group enriched"	"Detected in some"	9	"hippocampal formation: 0.8;pons and medulla: 1.1"	"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	96.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.3	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 83.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.3;U-87 MG: 2.1"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0"	"Region enriched"	"Detected in single"	13	"cerebellum: 4.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA023219	Uncertain									"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.4	0.1	0.2	0.2	0.3	0.0	0.2	4.2	0.2	2.2	0.2	0.2	0.2	0.2	0.2	0.2	2.5	1.0	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.2	0.2	0.2	1.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	0.2	4.3	0.2	0.2	18.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.4	83.5	9.2	0.2	2.0	0.6	0.0	0.1	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.2	0.2	0.4	1.0	1.1	0.2	0.0	1.3	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.6	0.3	0.5	0.0	0.0	0.7	0.5	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.3	4.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822472-8887001	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 131.6;lymphoid tissue: 67.9;tongue: 54.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 12.1;hTCEpi: 6.0;SK-BR-3: 15.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	34000000	34000000			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.1	0.6	31.3	0.1	0.1	0.1	0.0	0.6	0.2	131.6	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	1.3	0.1	0.2	0.1	0.1	17.3	0.1	0.1	18.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	1.2	0.1	54.7	67.9	0.3	28.7	1.0	1.2	1.8	2.0	1.5	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.7	12.1	0.0	6.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.7	0.4	0.9	1.0	0.7	0.9	0.4	0.4	0.3	1.0	0.5	0.6	1.7	1.5	2.0	1.2	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	6.5	0.0	0.0	0.1	1.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in all"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		69000000	69000000	"Actin filaments"	"Actin filaments"	"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.7	11.9	0.0	7.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA007131: AB_2667756, HPA007158: "	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.7	0.0	13.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Group enriched"	"Detected in many"	10	"ASC diff: 186.6;Hep G2: 316.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"											"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favourable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.6	0.1	25.8	186.6	22.5	0.0	0.8	5.7	0.3	0.2	0.5	0.0	0.0	0.3	5.8	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.2	316.4	1.8	0.1	0.0	11.4	1.6	2.7	1.6	0.6	5.5	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Group enriched"	"Detected in some"	4	"A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	134.6	0.1	14.2	167.1	5.7	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	3.8	0.0	0.7	0.0	0.0	0.0	0.0	38.0	251.2	0.3	0.0	0.0	14.9	8.4	0.7	0.7	0.0	5.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.2	76.9	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.9	0.0	0.0	0.0	0.0	1.7	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"		5800000	5800000	Cytosol	Cytosol	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ALPK2	HAK	ENSG00000198796	"Alpha kinase 2"	Q86TB3	18	58481247-58628957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4"	"Cell line enhanced"	"Detected in many"		"BJ: 26.0;BJ hTERT+: 15.8;fHDF/TERT166: 23.5;U-138 MG: 13.3"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in many"			"HPA027377, HPA027976, HPA028084, HPA029801"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006"	"unprognostic (7.35e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.60e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (5.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.20e-2)"	0.8	0.0	0.1	2.8	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.8	0.0	0.4	35.3	0.1	0.0	5.2	2.8	0.1	3.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.2	0.4	0.1	35.3	0.3	0.6	0.1	0.1	0.2	1.2	0.6	0.1	5.5	0.3	12.4	7.9	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	6.9	0.5	0.0	0.2	1.8	0.1	26.0	15.8	11.0	9.5	1.6	0.0	0.0	2.7	23.5	0.0	0.0	0.0	11.3	5.6	0.0	0.0	2.1	0.9	1.4	0.0	0.0	1.6	0.0	3.3	0.1	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.3	5.8	1.8	4.4	10.7	9.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ANKK1	X-kinase	ENSG00000170209	"Ankyrin repeat and kinase domain containing 1"	Q8NFD2	11	113387791-113400418	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 9.7;tongue: 6.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 6.5;RT4: 3.1;U-266/70: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012813	Uncertain									"HPA012813: AB_1844832"	"unprognostic (5.63e-3)"	"unprognostic (6.67e-3)"	"unprognostic (5.09e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.56e-4)"	"unprognostic (7.02e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.39e-6)"	"unprognostic (3.17e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.65e-2)"	0.6	0.5	0.6	0.6	2.0	0.4	1.2	0.6	1.4	1.5	0.6	0.6	0.6	0.4	0.7	0.9	0.6	3.3	0.6	0.6	0.6	1.2	0.6	0.6	0.6	1.1	0.6	0.6	1.0	0.6	0.4	4.7	0.6	0.6	1.9	0.1	0.6	1.8	1.0	0.7	9.7	0.6	0.6	2.3	0.9	0.2	1.0	0.6	0.6	1.2	6.3	1.5	0.6	1.2	1.3	0.2	1.4	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.1	0.3	3.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.6	0.0	0.0	0.1	0.0	1.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.0	1.3	0.2	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.6	2.0	0.6	1.4	0.6	1.2	0.6	0.6	0.6	0.6
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88822132-88851818	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.2;stomach 1: 27.6;tongue: 29.0"	"Cell line enhanced"	"Detected in some"		"A-431: 8.8;CAPAN-2: 28.2;HaCaT: 6.9;HL-60: 8.3;RT4: 19.0;T-47d: 12.9;U-937: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 15.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 15.4;monocytes: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favourable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavourable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.4	0.5	2.3	8.4	3.6	5.3	2.3	0.3	3.2	6.7	6.7	0.5	0.0	2.0	0.3	0.2	21.9	0.3	4.3	1.1	4.0	0.6	6.0	1.6	1.3	6.1	3.6	0.2	0.3	40.2	0.1	1.6	0.2	2.7	2.0	7.2	0.1	3.7	0.0	0.3	18.5	2.1	1.3	7.4	8.8	27.6	0.3	1.4	7.9	0.3	29.0	14.6	4.4	8.6	0.1	0.4	15.4	6.8	0.5	0.8	1.2	8.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.1	0.1	0.0	6.9	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.1	0.1	0.0	0.0	0.0	0.1	19.0	0.0	0.0	0.0	1.4	0.0	12.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.6	0.1	0.1	4.8	2.5	0.1	6.8	0.0	0.0	0.4	0.1	0.4	0.1	0.8	0.2	15.4	0.5	1.2	0.4	0.0	1.2	2.3	3.6	0.3	3.2	4.0	0.6	3.6	0.2	2.7	1.4
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	77000000	77000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.57e-5)"	"prognostic unfavourable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	65.9	104.2	4.7	4.9	66.5	63.3	0.3	114.3	71.4	47.3	32.1	3.0	59.7	0.1	37.8	99.7	81.2	10.1	69.2	37.5	37.3	0.7	5.0	31.0	0.1	53.1	11.0	2.5	36.4	57.4	47.8	94.0	67.0	20.9	2.8	58.3	0.2	19.4	6.0	5.9	42.4	0.0	26.6	0.2	106.4	14.0	0.0	0.0	39.3	1.0	26.4	0.2	1.7	82.7	55.5	34.9	76.2	58.6	0.4	0.1	0.2	128.1	10.2	83.4	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 75.4;tongue: 34.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 71.2;HBEC3-KT: 108.3;hTCEpi: 28.7;SiHa: 25.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;monocytes: 3.2"									"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	4.8	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.7	1.2	35.9	1.2	0.0	0.9	0.0		0.0	0.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.9	0.0	0.0	1.1	0.7	0.0	75.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	34.2	13.3	6.9	0.6	0.0	5.0	0.8	3.2	0.5	0.0	0.5	14.2	3.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.0	71.2	0.0	108.3	0.0	6.1	0.0	0.0	6.9	0.0	2.5	0.0	0.1	0.0	28.7	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.0	16.6	0.0	0.0	25.6	2.2	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5										
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179083	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.4;tongue: 17.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 12.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.9	0.6	0.2	1.3	0.3	1.2	0.5	11.4	0.7	0.6	1.2	0.3	0.9	1.3	1.3	1.9	1.1	1.0	0.6	12.6	0.7	0.4	0.8	0.4	0.7	1.9	0.6	0.2	1.1	7.0	1.6	1.8	0.3	0.8	1.7	0.0	2.7	1.2	0.1	38.4	1.9	1.3	4.1	0.2	1.8	1.3	0.6	0.3	0.0	0.9	17.6	1.1	1.6	1.5	4.4	2.9	9.6	2.4	4.0	4.5	2.7	2.1	4.0	4.9	4.5	0.0	0.0	4.0	4.4	0.0	0.0	0.0	3.0	2.4	3.2	2.7	0.0	5.1	0.0	0.0	0.0	5.0	7.2	2.0	7.0	3.4	0.0	2.2	6.5	0.0	0.0	0.0	0.0	0.0	3.7	8.1	0.0	3.5	2.6	4.0	1.4	4.8	8.2	4.7	4.9	0.0	3.3	5.0	2.8	2.0	0.6	0.7	6.4	2.0	2.2	6.1	5.6	3.7	2.8	12.5	6.1	3.1	1.4	3.1	4.0	4.0	2.4	9.6	3.1	2.2	3.7	4.4	3.3	3.0	1.2	3.8	4.5	2.8	7.3	4.0	1.9	2.9	3.2	2.7	0.2	0.3	11.4	0.6	0.7	0.4	0.6	0.2	0.8	0.3
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.4;testis: 27.5;tongue: 20.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 15.9;HBEC3-KT: 36.3;hTCEpi: 40.8;hTERT-HME1: 39.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	12.7	0.1	0.0	1.6	0.1	0.0	0.9	0.0	0.4	2.7	1.5	0.1	0.0	0.0	0.4	10.8	13.4	0.8	0.1	1.4	0.1	0.0	0.1	0.1	0.7	1.3	0.2	0.2	0.6	0.0	0.0	0.0	1.9	0.5	0.4	0.0	0.7	1.7	0.2	0.1	7.9	0.2	0.3	0.3	0.1	0.0	27.5	0.0	6.0	0.2	20.2	3.7	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.3	2.1	0.0	0.6	0.1	6.9	9.7	0.0	0.1	0.0	0.3	4.2	15.9	0.8	36.3	12.6	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.8	40.8	6.2	39.8	6.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Cell line enriched"	"Detected in some"	5	"RT4: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"					"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40770080-40772449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.5;SK-BR-3: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			HPA044636	Approved									"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.5	0.9	0.8	1.5	1.1	1.5	1.1	4.0	1.7	1.7	1.0	0.8	0.8	2.0	1.1	0.8	22.8	0.9	1.4	0.8	0.8	0.6	0.9	1.9	1.6	2.1	1.1	0.8	1.3	0.9	0.0	1.3	0.8	0.9	1.1	0.0	0.8	5.4	1.8	1.9	11.9	1.8	0.8	0.8	1.5	1.2	0.9	0.8	1.8	1.0	18.8	21.9	0.9	3.8	0.4	0.7	0.0	0.1	0.4	1.0	0.1	0.6	0.5	1.8	2.2	0.7	0.2	0.4	0.8	0.2	0.0	0.2	2.0	2.4	1.1	2.0	0.0	4.4	0.8	0.0	0.0	1.6	1.8	1.1	4.0	0.6	0.0	0.9	1.4	0.2	1.0	0.0	0.1	0.6	0.9	1.3	0.0	0.5	1.4	1.7	0.7	0.8	1.5	0.3	0.5	19.5	1.6	3.9	0.9	0.6	6.2	0.2	2.2	1.4	0.9	2.2	1.0	2.0	0.7	1.5	1.0	1.0	0.7	3.3	0.7	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.9	0.6	0.0	0.4	1.0	1.0	0.0	0.4	0.0	0.7	0.8	0.1	0.8	1.1	4.0	0.9	0.8	0.6	1.1	0.8	0.9	0.8
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.1	1.3	0.1	0.1	0.0	15.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	3.1	1.0	0.0	0.0	56.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell line enhanced"	"Detected in many"		"A-431: 27.2;CACO-2: 24.8;CAPAN-2: 20.6;HaCaT: 18.4;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	27.2	0.3	0.0	0.1	0.1	3.2	13.5	1.6	2.0	3.8	4.0	24.8	20.6	0.0	2.9	2.7	18.4	0.0	8.3	2.5	2.2	3.8	1.3	2.4	5.5	1.0	0.0	0.1	1.9	15.4	2.9	4.3	0.0	0.7	0.2	0.7	9.5	0.3	0.1	1.8	0.7	0.1	0.0	0.1	2.9	12.3	1.5	0.0	2.4	16.6	0.0	12.1	0.1	0.4	0.2	1.8	6.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 69.8"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	69.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.1;skin 1: 17.3;tongue: 12.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 7.1;SK-BR-3: 9.7;T-47d: 21.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.4	1.9	0.4	0.9	0.4	0.1	3.2	0.4	0.7	4.0	0.4	0.4	0.4	2.1	0.8	1.0	12.1	0.3	0.6	0.4	0.4	0.3	0.7	1.1	0.7	1.0	0.4	0.4	1.0	0.4	0.0	0.4	3.0	0.6	2.1	0.0	0.4	6.2	3.6	0.6	17.3	1.6	0.4	1.5	1.8	0.5	0.8	0.4	0.4	0.4	12.3	10.7	1.3	5.8	2.0	0.0	0.0	0.5	0.0	0.4	0.1	3.8	0.5	0.6	0.2	0.0	0.0	3.8	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	2.0	0.2	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	1.2	0.0	7.1	0.0	0.0	0.1	0.4	0.0	1.6	0.4	0.0	3.0	0.5	0.1	0.0	9.7	1.5	21.6	0.0	0.2	0.1	0.5	0.3	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.3	2.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.4	0.4	0.7	0.4	0.3	0.4	0.4	0.6	0.4
CARD18	"ICEBERG, pseudo-ICE, UNQ5804"	ENSG00000255501	"Caspase recruitment domain family member 18"	P57730	11	105137721-105139726	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 8.2;skin 1: 26.7;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;EFO-21: 1.7;hTCEpi: 5.6;U-2 OS: 5.9;U-266/84: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.1"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038582	Approved									"HPA038582: AB_10960549"		"unprognostic (3.90e-1)"				"unprognostic (2.95e-1)"			"unprognostic (1.77e-1)"					"unprognostic (2.88e-1)"	"unprognostic (3.42e-1)"			0.1	0.0	0.1	0.1	1.2	0.0	8.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.0	0.1	0.3	0.1	0.1	26.7	0.1	0.1	0.1	0.1	0.0	0.5	0.1	1.8	0.1	6.6	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	6.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.0	3.4	1.5	3.0	11.8	18.3	2.3	13.2	15.6	15.1	12.1	0.1	2.6	0.0	3.9	13.5	5.6	2.0	2.6	6.1	16.4	6.3	0.5	3.6	0.1	1.0	0.0	0.0	2.6	0.3	10.5	1.3	9.1	0.0	0.1	4.4	9.0	1.1	5.3	1.2	15.3	2.5	2.9	23.4	5.0	5.1	0.8	1.1	10.1	12.3	19.2	3.6	1.4	6.2	9.8	0.8	11.0	12.7	0.5	0.2	0.0	10.2	0.3	17.6	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;HUVEC TERT2: 4.9;LHCN-M2: 7.5;TIME: 17.0;U-2197: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	4.9	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.4	0.0	9.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 125.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"					"Region enriched"	"Detected in some"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"					"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115090-31120446	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"placenta: 19.2;skin 1: 109.3;tongue: 29.7"	"Cell line enriched"	"Detected in single"	7	"A-431: 5.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0"	"Low region specificity"	"Detected in some"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"					"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	29.7	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457707	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6;tongue: 33.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 18.1;RH-30: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved									"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	4.5	11.5	5.7	1.9	5.1	6.1	3.7	2.3	4.4	3.4	2.0	4.5	3.7	2.3	2.4	5.5	3.6	2.9	1.6	5.0	4.8	3.9	3.9	5.5	2.4	2.6	6.0	3.5	2.9	18.2	8.3	2.5	5.8	4.0	2.6	2.1	4.5	4.5	2.6	81.6	4.0	2.2	2.6	5.1	3.1	2.0	1.2	4.4	4.5	6.0	33.9	3.2	2.4	2.5	7.8	8.2	15.2	11.1	12.3	11.7	7.1	0.8	1.1	2.0	2.4	3.2	2.2	4.5	0.6	2.0	3.0	2.5	0.7	1.1	3.2	2.2	1.2	7.1	0.7	13.0	1.1	3.9	2.5	1.8	1.2	4.1	1.4	1.1	4.6	4.8	3.6	1.8	5.8	2.0	2.3	1.8	18.1	0.5	3.4	2.1	1.4	0.6	2.2	37.6	8.0	8.1	0.7	0.3	5.9	1.2	2.2	2.4	2.1	1.5	1.9	1.3	3.5	0.9	2.5	4.3	4.7	0.9	1.1	2.5	1.1	10.6	6.6	15.2	9.9	7.2	7.7	7.8	11.0	10.0	8.2	7.6	9.0	11.7	2.2	12.3	11.1	6.3	8.9	7.1	5.7	5.1	2.3	4.1	4.8	3.9	6.0	3.5	4.0	4.4
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell line enriched"	"Detected in some"	5	"hTCEpi: 67.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	66000	66000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	12.3	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	67.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Plasma membrane"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favourable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.7	0.0	55.3	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.1	0.0	98.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 160.3;MCF7: 61.1;T-47d: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.2	0.5	11.7	0.1	15.3	22.9	0.0	21.8	160.3	1.7	2.2	18.2	37.8	0.1	10.8	23.1	13.3	2.8	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.0	0.0	0.2	7.2	1.0	2.5	0.0	0.0	0.0	0.2	0.1	61.1	0.1	0.1	14.1	5.7	0.1	0.0	0.3	0.2	0.4	29.2	2.1	0.3	37.8	0.1	124.2	0.0	0.0	0.4	6.7	3.6	1.3	0.9	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Cell line enriched"	"Detected in single"	11	"CAPAN-2: 10.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavourable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HaCaT: 1.1;HL-60: 1.2;K-562: 2.0;TIME: 1.2;U-266/84: 1.0;U-698: 1.5;U-937: 1.7"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					36000	36000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	57.1	0.2	0.0	0.0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	49.6	0.2	0.2	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	139.6	187.9	0.3	81.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.0	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		39000000	39000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favourable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.6	0.1	0.0	0.3	3.8	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.6	10.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	13.3	0.2	3.7	146.6	0.3	14.4	0.0	0.0	3.5	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.6	0.8	1.1	0.1	91.6	0.0	0.2	2.4	0.0	0.1	0.0	0.1	58.3	3.2	29.1	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		6100000	6100000	Cytosol	Cytosol	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102415	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;CAPAN-2: 20.5;HaCaT: 29.6;hTCEpi: 32.0;SK-BR-3: 18.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.4;neutrophil: 5.7"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 20.4"	"Not detected"	"Not detected"							"HPA011911, HPA012615"	Enhanced					14000000	14000000			"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (3.01e-4)"	3.3	1.1	1.1	9.8	1.1	0.0	6.3	0.7	0.9	38.1	23.6	0.6	0.2	12.1	3.0	2.4	127.5	1.5	1.1	9.5	1.0	0.9	4.7	4.3	3.3	6.3	1.1	0.6	1.0	3.8	11.8	0.7	20.0	1.1	4.5	13.3	1.3	22.4	0.0	0.7	4.4	33.5	0.8	1.7	6.1	12.6	0.9	0.7	4.8	2.5	163.9	68.2	1.0	39.6	0.0	0.0	20.4	1.5	0.0	0.0	0.3	7.3	0.7	1.2	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	3.8	20.5	0.0	0.3	0.0	29.6	4.9	2.1	0.0	0.0	2.9	11.0	3.6	6.6	0.1	0.0	0.2	0.1	32.0	0.0	3.1	0.0	5.3	0.0	0.0	5.9	0.0	0.4	4.8	7.3	5.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	18.8	0.0	5.0	7.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	20.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	1.1	1.1	0.7	0.9	1.0	0.9	1.1	0.6	1.1	0.7
DSG1	"CDHF4, DSG"	ENSG00000134760	"Desmoglein 1"	Q02413	18	31318089-31357029	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 124.8;tongue: 117.4"	"Cell line enriched"	"Detected in single"	18	"hTCEpi: 14.2"	"Group enriched"	"Detected in many"	10	"head and neck cancer: 57.0;melanoma: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"CAB009394, HPA022128"	Enhanced					140000000	140000000			"CAB009394: AB_2293011, HPA022128: AB_1847620"	"unprognostic (2.55e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.22e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.44e-1)"		"prognostic unfavourable (2.99e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	30.9	0.0	0.0	0.0	0.0	1.3	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	4.2	0.0	0.3	124.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	117.4	2.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447795-31478702	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9"	"Group enriched"	"Detected in some"	7	"HaCaT: 41.1;hTCEpi: 101.8"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046864, HPA056863, CAB069880"	Enhanced									"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.90e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.1	35.9	1.1	0.0	0.0	1.6	2.3	0.0	156.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	10.6	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.0	158.9	50.7	0.4	24.8	0.2	0.1	9.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.8	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.5;HaCaT: 49.1;HBEC3-KT: 35.3;hTCEpi: 111.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		110000000	110000000	"Cell Junctions"	"Cell Junctions"	"CAB037324: , HPA045840: AB_2679468, HPA054950: "	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favourable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.6	6.2	0.0	0.0	0.9	1.4	45.5	4.0	3.5	2.0	2.0	17.7	5.4	0.0	5.8	6.5	49.1	7.5	35.3	0.3	0.0	8.7	0.0	3.5	23.8	0.0	0.1	0.1	0.3	111.4	1.8	20.4	0.0	0.0	0.0	3.6	9.7	0.0	0.1	0.9	3.1	0.0	0.0	5.2	7.5	5.6	2.1	0.0	4.6	9.8	0.0	11.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 75.2;testis: 18.6;tongue: 26.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;EFO-21: 5.7;Hep G2: 11.9;K-562: 4.6;LHCN-M2: 10.6;RH-30: 9.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 3.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.2	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.3	0.0	75.2	0.1	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	1.0	26.0	1.9	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.1	0.1	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.9	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	4.6	0.0	10.6	0.6	0.0	0.0	0.7	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 42.1;placenta: 86.0;tongue: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;SK-BR-3: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"					"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	0.6	0.1	1.3	0.2	1.4	0.2	1.2	0.2	1.1	7.5	0.2	0.2	0.2	0.1	0.3	0.8	42.1	0.6	0.4	0.4	0.7	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.9	0.2	0.1	0.2	86.0	0.5	0.2	0.1	0.2	9.3	0.2	0.2	13.5	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.5	0.4	28.8	21.6	0.2	10.9	0.2	0.2	0.8	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	2.4	1.5	0.3	1.9	1.6	1.4	0.2	0.1	4.3	1.0	0.2	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	1.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.6	0.1	0.2	0.0	0.3	0.4	0.1	1.2	0.2	2.4	2.3	0.8	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.3	1.4	0.2	0.7	0.7	0.1	0.4	0.3	0.5	0.2
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Group enriched"	"Detected in some"	6	"hTCEpi: 61.2;U-2197: 27.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA014420: "	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavourable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.1	0.0	61.2	1.0	4.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.2	1.1	0.0	0.1	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;NTERA-2: 5.9;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.2	0.6	1.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.7	0.8	0.5	6.3	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.3	0.4	0.0	1.0	0.1	0.8	5.9	0.8	0.0	0.0	0.1	0.2	1.3	2.6	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.8	0.1	0.3	0.1	0.6	0.8	0.1	0.2	0.2	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 58.9;hTEC/SVTERT24-B: 18.5;U-2197: 40.1;U-87 MG: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	8.9	0.0	0.0	0.8	1.5	0.0	2.0	58.9	0.5	0.3	6.9	16.7	0.0	9.8	0.0	0.5	0.0	12.8	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.5	18.5	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	40.1	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	28000000	28000000	Cytosol	Cytosol	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FAM240B		ENSG00000283329	"Family with sequence similarity 240 member B"	A0A1B0GVZ2	9	38694263-38720428	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.9;tongue: 6.0"	"Low cell line specificity"	"Detected in some"											"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.8"																																	0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.0	0.4	0.1	0.1		0.1	0.1	0.1	0.6	0.1	0.1	0.1	2.6	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	1.5	0.3	0.1	0.1	0.8	0.0	1.6	0.1	0.1	0.2	6.0	0.1	0.1	0.1	1.5	1.6	6.9	0.8	1.2	0.7	0.5	1.0	0.7	0.5	0.7	0.0	1.0	0.5	0.0	0.2	0.2	0.0	1.9	0.7	0.2	0.3	0.0	1.6	0.0	0.4	0.3	1.0	0.5	0.8	1.7	0.4	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.4	0.2	0.9	0.4	0.9	0.0	1.2	0.0	0.0	0.3	1.1	0.3	0.4	0.2	1.7	1.2	0.2	0.0	0.4	0.1	1.2	0.8	0.8	1.5	0.4	0.0	0.6	0.0	6.9	0.8	1.5	0.6	0.7	0.5	1.1	0.6	0.6	0.3	1.5	0.6	0.7	3.9	1.2	0.6	1.6	0.4	0.5										
FAM25A	bA96C23.5	ENSG00000188100	"Family with sequence similarity 25 member A"	B3EWG3	10	87020306-87024730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.5;skin 1: 30.9;tongue: 61.1;vagina: 30.8"	"Group enriched"	"Detected in some"	6	"A-431: 13.3;SK-BR-3: 39.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-1)"				"unprognostic (7.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.05e-5)"						"unprognostic (1.21e-1)"	0.2	0.1	0.2	0.2	0.2	0.0	1.9	0.2	0.2	21.6	0.2	0.2	0.2	0.0	1.1	0.2	85.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.0	0.2	19.9	0.2	0.3	30.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	61.1	16.9	0.2	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	39.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 31.9;hTERT-HME1: 16.4;NTERA-2: 16.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	3.9	1.2	0.5	0.6	0.9	2.7	0.9	11.1	4.4	7.6	2.5	0.0	4.7	1.5	6.2	0.6	10.1	3.0	0.0	0.6	0.1	1.5	1.3	5.6	0.0	0.1	2.5	31.9	3.4	16.4	0.1	0.2	0.0	1.4	1.4	0.0	0.6	16.7	0.7	0.2	0.0	0.1	10.8	0.0	0.4	0.3	5.3	11.9	6.9	9.4	0.1	0.2	2.7	9.2	0.3	0.5	0.1	0.4	0.0	0.5	0.0	1.6	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54942022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.7;intestine: 24.6;tongue: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 12.3;HaCaT: 13.8;HBEC3-KT: 7.5;hTCEpi: 13.9;hTERT-HME1: 18.3;RT4: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031464, HPA031465"	Enhanced									"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavourable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.86e-5)"	0.4	0.4	0.4	6.9	0.4	0.0	1.6	0.4	0.4	8.8	16.4	0.0	1.9	6.5	0.4	2.9	32.7	1.4	7.0	1.6	0.4	0.4	6.3	0.5	0.5	0.0	0.4	0.0	0.5	3.7	0.0	0.4	15.6	0.0	5.5	8.2	0.0	5.5	1.7	3.5	22.3	24.6	1.3	0.4	0.4	3.6	0.9	0.0	4.3	11.0	30.1	8.5	4.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	5.3	2.8	0.0	0.0	0.0	13.8	0.0	7.5	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	18.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.7	15.8	0.1	0.0	2.4	0.4	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292401	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain									"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.1	29.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	22.3	12.1	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.4	0.2	0.3	2.0	0.0	0.5	0.0	0.0	0.4	0.2	0.5	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.8	0.1	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004804	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.0;skin 1: 33.8;tongue: 28.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	1.8	1.0	0.5	5.1	0.8	0.6	2.2	1.0	0.8	6.2	5.5	0.4	1.3	6.6	1.4	0.9	36.0	0.8	13.4	8.7	0.9	0.6	2.6	26.5	2.3	1.5	0.4	0.4	1.1	7.0	4.7	2.2	2.6	1.6	1.7	3.2	1.5	5.7	3.0	3.4	33.8	10.1	1.6	0.4	1.0	5.9	0.8	0.3	3.2	3.3	28.9	19.1	2.4	6.9	1.5	0.2	3.4	0.7	0.0	2.6	0.7	12.7	11.8	0.1	0.0	0.4	1.1	19.6	13.5	5.9	11.4	8.6	15.1	4.7	8.4	8.3	8.8	15.2	1.9	11.3	5.3	6.9	4.3	0.2	5.8	8.2	8.5	1.5	4.3	1.5	21.2	7.4	12.3	4.1	4.0	0.3	3.2	7.8	0.3	3.1	6.0	0.0	0.0	0.0	4.1	5.6	3.3	6.1	0.0	4.6	2.9	0.8	5.0	1.9	7.6	7.1	11.9	3.3	15.5	1.2	2.0	2.1	5.5	0.0	4.6	3.4	0.0	0.0	2.6	0.1	1.4	1.1	1.5	0.8	0.2	1.5	1.4	0.2	0.0	0.0	0.7	0.2	1.8	0.7	0.5	0.8	1.0	0.8	0.9	0.6	0.4	0.4	1.6	0.3
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell line enriched"	"Detected in single"	93	"NTERA-2: 18.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"					"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in some"	4	"HaCaT: 77.2;HBEC3-KT: 133.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	1.5	0.0	77.2	0.0	133.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;NTERA-2: 4.4;TIME: 3.0;U-2 OS: 3.4;U-2197: 3.6"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		500000	500000	"Cytoplasmic bodies"	"Cytoplasmic bodies"	"CAB002210: AB_563731, HPA027505: , HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	14.0	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	3.0	1.2	3.4	3.6	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.0;tongue: 33.3"	"Cell line enriched"	"Detected in some"	6	"RH-30: 31.9"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"					"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.2	6.3	3.4	0.6	5.1	0.6	0.9	26.7	13.6	1.0	0.8	1.7	0.0	0.9	2.1	1.5	4.9	2.6	1.4	15.9	3.6	4.1	0.9	8.6	1.0	0.6	5.0	3.7	3.0	0.8	2.5	2.3	0.8	9.5	2.0	0.7	8.2	12.3	1.0	110.0	0.6	1.0	1.5	2.8	0.6	2.3	1.3	1.7	0.0	1.0	33.3	1.3	0.9	0.4	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.2	0.0	1.3	0.1	0.4	0.1	0.5	0.1	0.9	0.2	0.1	0.6	0.3	0.0	3.8	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	0.1	0.1	0.1	1.3	0.1	0.4	31.9	0.2	0.0	0.0	5.4	0.9	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.6	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.1	26.7	13.6	3.6	4.1	5.0	3.7	9.5	1.7
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 92.9;U-2197: 62.3;WM-115: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.80e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.0	5.3	0.6	2.4	5.4	5.4	5.2	33.8	31.0	29.3	16.4	1.6	30.1	0.0	7.4	23.4	6.8	2.2	27.2	25.2	1.1	0.0	2.2	0.5	4.0	6.8	1.4	0.8	2.3	2.7	22.9	34.7	9.4	5.2	0.2	38.4	1.5	0.0	3.0	2.5	92.9	0.1	2.9	0.1	13.6	2.4	0.0	0.0	2.0	0.0	25.4	0.1	1.3	23.3	34.7	7.1	62.3	49.5	0.0	0.1	0.1	48.8	0.6	140.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3
FOXN1	"FKHL20, RONU, WHN"	ENSG00000109101	"Forkhead box N1"	O15353	17	28506243-28538896	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.1;lymphoid tissue: 37.0;skin 1: 27.9;tongue: 18.4"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 15.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 7.0;head and neck cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.60e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (2.68e-3)"	"unprognostic (5.98e-6)"		"prognostic favourable (5.00e-4)"		"unprognostic (2.85e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.6	0.0	15.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	1.6	0.2	0.1	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	37.0	0.1	18.4	11.3	0.7	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1										
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;HaCaT: 31.1;HBEC3-KT: 13.9;hTCEpi: 51.5;RT4: 17.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain									"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	31.1	0.0	13.9	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	51.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	1.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232395	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.5;esophagus: 97.1;tongue: 43.6"	"Cell line enriched"	"Detected in some"	9	"RT4: 63.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Lineage enhanced"	"Detected in many"		"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA014846: "	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	1.2	1.0	15.3	1.1	17.0	50.5	3.3	9.0	15.9	16.9	1.0	1.9	0.0	1.0	1.6	1.1	97.1	1.2	1.8	1.0	16.3	7.9	1.0	1.0	1.1	1.4	11.1	11.3	1.0	1.0	1.0	0.7	1.0	9.2	1.1	1.1	0.0	8.7	1.0	1.0	18.7	1.0	1.0	3.7	1.1	1.2	1.7	6.0	7.9	4.1	43.6	15.7	6.3	30.9	1.4	0.0	1.2	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.4	2.7	1.5	1.2	0.0	0.0	0.0	5.7	0.6	15.3	17.0	9.0	15.9	16.3	7.9	11.1	11.3	9.2	6.0
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell line enhanced"	"Detected in some"		"A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"				"Lipid droplets, Mitochondria"	"Lipid droplets, Mitochondria"	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	24.6	0.0	32.8	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	43.8	0.0	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.7	0.0	0.0	0.0	1.1	12.9	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.5;HaCaT: 16.9;MCF7: 26.0;RT4: 29.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.1	0.0	0.0	26.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	2.1	29.7	0.1	0.0	0.0	2.9	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		7100	7100	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	7.1	0.0	0.1	0.5	0.9	0.6	0.4	0.0	0.3	1.6	0.0	4.9	0.8	9.6	0.0	0.2	2.3	0.0	1.0	0.0	0.2	0.1	0.1	0.6	0.0	0.8	0.2	0.6	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Cell line enhanced"	"Detected in some"		"A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA023670, HPA024767, HPA026317"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA023670: , HPA024767: , HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HFE2	"haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC"	ENSG00000168509	"Hemochromatosis type 2 (juvenile)"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 49.4;skeletal muscle: 128.9;tongue: 28.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HSkMC: 4.9;K-562: 4.7;RH-30: 1.7"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"													42000	42000				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	0.0	0.0	14.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	128.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.2	2.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	4.9	0.0	0.0	0.0	0.0	4.7	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H3E	"H3.1, H3/d, H3FD"	ENSG00000274750	"Histone cluster 1 H3 family member e"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;SCLC-21H: 13.5;T-47d: 8.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	4.8	0.0	2.8	1.2	0.2	2.6	2.4	1.2	2.6	3.6	1.9	5.2	6.1	2.5	6.9	14.5	1.6	3.0	7.4	0.0		0.7	0.9	2.1	4.1	4.1	0.0	2.5	0.6	2.5	0.5	2.9	1.8	4.6	2.4	0.5	4.4	1.8	6.1	1.3	6.1	2.5	1.8	2.3	3.5	19.9	3.2	22.4	3.6	25.6	8.8	2.7	0.3	2.6	3.9	6.5	1.8	0.5	3.1	1.4	2.0	2.2	3.2	1.4	3.8	1.8	0.2	1.5	1.7	0.8	0.6	0.7	1.2	0.0	12.0	0.6	2.5	0.0	0.4	0.7	3.1	2.8	0.4	1.0	0.7	1.2	0.2	1.9	2.7	2.7	0.3	0.8	1.2	0.3	2.5	2.2	1.9	0.4	0.1	0.2	2.2	1.5	0.6	0.3	6.5	1.2	13.5	1.6	2.1	3.3	3.7	8.2	1.3	0.6	1.5	0.5	0.4	0.3	0.9	0.3	0.2	0.7	0.1	0.8	0.4	1.8	0.0	1.3	1.5	1.7	1.4	1.8	1.7	1.2	2.6	1.7	1.8	6.5	0.5	1.3	3.9	3.1	1.4										
HOXC13	"HOX3, HOX3G"	ENSG00000123364	"Homeobox C13"	P31276	12	53938765-53946544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.4;skin 1: 13.5;tongue: 4.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.4;HaCaT: 32.4;SK-BR-3: 17.9;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051634	Enhanced									"HPA051634: AB_2616459"	"unprognostic (5.16e-3)"	"unprognostic (1.46e-1)"		"unprognostic (1.29e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.78e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.77e-2)"	"unprognostic (9.74e-9)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.68e-1)"	2.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	2.5	0.0	0.6	13.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.1	0.0	15.4	0.2	0.0	9.2	0.9	2.1	1.4	0.8	1.3	0.2	0.0	0.2	0.0	32.4	3.9	1.0	0.8	0.0	3.1	0.0	4.2	0.0	0.0	0.0	3.3	0.0	7.6	0.0	3.0	0.0	5.5	0.0	5.6	9.5	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	5.1	17.9	2.3	13.8	0.0	0.0	0.0	6.7	0.1	2.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
HR	"ALUNC, AU"	ENSG00000168453	"HR, lysine demethylase and nuclear receptor corepressor"	O43593	8	22114415-22133384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 50.5;tongue: 23.8"	"Cell line enhanced"	"Detected in some"		"A549: 10.0;EFO-21: 9.9;HaCaT: 38.4;SiHa: 13.3;T-47d: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054888			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054888: AB_2682630"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.68e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	2.6	1.8	3.8	3.2	6.1	0.8	4.7	19.8	17.0	2.1	7.5	9.6	0.1	5.5	1.5	0.9	12.1	1.9	6.7	1.9	5.3	4.0	0.9	0.8	1.2	1.0	6.1	6.8	0.8	1.3	0.7	1.7	0.9	4.9	2.3	4.0	6.7	3.4	5.4	1.1	50.5	5.3	2.3	3.8	1.1	8.4	5.2	6.6	0.0	2.6	23.8	4.4	3.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	9.9	0.7	38.4	0.0	0.9	0.0	0.0	0.0	0.0	8.1	0.0	2.2	0.0	0.0	2.0	6.2	0.0	0.6	0.0	0.0	0.1	0.0	5.7	0.6	0.1	0.0	7.7	0.8	0.0	0.2	0.1	2.6	0.4	2.2	13.3	3.0	3.0	14.2	0.0	0.0	0.2	8.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.1	19.8	17.0	5.3	4.0	6.1	6.8	4.9	6.6
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455601-54456384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 37.1;fHDF/TERT166: 16.6;HSkMC: 7.3;LHCN-M2: 5.4"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA062124			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.7	0.1	1.1	0.1	1.0	0.0	0.5	0.0	2.7	0.2	1.0	0.0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106.0	0.5	0.4	0.0	0.0	0.5	0.0	0.1	1.1	0.3	0.0	0.0	0.9	0.0	0.2	2.0	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0.0	0.2	0.2	0.3	0.0	0.0	0.1	22.3	0.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.1	0.0	0.0	0.1	16.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	7.3	2.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	0.0	2.7	0.5	0.4	0.1	1.1	0.2	0.0
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229752-46231243	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 51.5;tongue: 29.7"	"Group enriched"	"Detected in some"	7	"HaCaT: 6.2;RT4: 22.8;SK-BR-3: 7.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA014001	Uncertain				"Secreted in other tissues"					"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.1	14.7	0.1	0.0	0.0	0.1	0.3	0.1	51.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	11.0	0.1	0.1	1.8	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.9	0.1	29.7	14.4	0.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.2	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.1	7.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 84.8;hTCEpi: 41.9;hTERT-HME1: 55.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.41e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.6	0.0	84.8	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	41.9	0.7	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"			Nucleoplasm	Nucleoplasm	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851379-55922853	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;tongue: 6.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"amygdala: 10.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 2.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.5;hippocampal formation: 1.1"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.3	0.1	10.3	1.0	0.1	5.3	0.2	0.1	0.4	0.2	1.5	0.0	0.0	0.4	1.2	1.8	1.7	0.1	0.2	0.4	1.6	0.2	0.3	0.3	0.5	0.1	0.1	0.0	0.5	0.7	0.0	0.7	0.7	0.0	1.0	0.4	0.4	1.3	0.2	2.6	2.5	0.8	1.8	0.1	0.3	0.5	5.9	0.0	1.4	0.5	6.4	0.5	0.5	2.2	0.0	1.2	0.2	2.2	0.0	0.1	0.4	0.1	1.1	0.0	0.0	0.0	0.4	0.5	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	8.9	1.8	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.0	6.0	3.0	4.3	10.8	3.3	0.0	0.4	1.4	0.0	0.0	1.4	0.0	6.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.5	0.5	16.0	0.0	1.0	0.0	0.0	0.0	18.5	0.0	2.5	0.1	2.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	10.3	0.1	0.1	0.4	1.6	0.2	0.1	0.0	0.0	0.0
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985665	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;BJ hTERT+: 1.9;HaCaT: 3.4;HMC-1: 3.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"						"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	10.9	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	2.8	0.1	0.1	22.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	94.1	31.5	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	2.5	0.0	0.0	0.0	0.7	0.0	1.9	0.1	1.3	0.0	0.0	0.0	0.8	0.0	3.4	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.6	0.3	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.6	0.4	0.0	1.2	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL36RN	"FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840"	ENSG00000136695	"Interleukin 36 receptor antagonist"	Q9UBH0	2	113058638-113065382	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 26.7;skin 1: 31.9;tongue: 68.9"	"Group enriched"	"Detected in some"	17	"BEWO: 21.5;U-87 MG: 16.6"	"Cancer enriched"	"Detected in some"	7	"head and neck cancer: 25.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (3.88e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"		"unprognostic (4.29e-1)"	"unprognostic (8.68e-3)"		"unprognostic (9.80e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"		"unprognostic (3.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.23e-3)"	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	68.9	26.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol	Cytosol	"HPA040721: "	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		8000000	8000000	Cytosol	Cytosol	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		61000000	61000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favourable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	30.2	25.1	2.5	2.1	0.0	0.0	39.3	1.7	10.4	0.7	0.6	37.9	33.5	0.6	18.7	1.1	126.0	3.6	28.0	0.1	0.0	8.9	1.3	20.0	8.3	4.2	0.8	13.4	0.0	63.6	0.1	5.2	11.2	11.1	11.0	0.0	38.8	0.2	10.9	4.9	4.2	35.4	0.0	22.7	19.4	77.4	6.2	4.6	3.9	76.5	0.2	63.8	0.9	17.6	0.0	1.8	0.8	0.5	0.9	3.4	0.6	0.1	1.4	0.3	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6
KBTBD13	"hCG_1645727, NEM6"	ENSG00000234438	"Kelch repeat and BTB domain containing 13"	C9JR72	15	65076816-65078192	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 4.6;skeletal muscle: 19.2;tongue: 9.4"	"Cell line enriched"	"Detected in single"	6	"HMC-1: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062737	Uncertain									"HPA062737: AB_2684856"										"unprognostic (1.18e-1)"		"unprognostic (7.88e-2)"			"unprognostic (6.07e-2)"			0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.1	0.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.4	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.2	1.6	0.7	0.7	0.2	3.7	0.0	0.0	0.0	0.8	2.6	0.8	1.1	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	1.4	2.2	0.7	1.7	0.9	0.7	1.0	2.1	1.5	0.0	0.3	1.0	0.2	12.1	2.7	0.5	0.7	1.2	0.6	2.1	0.0	0.6	1.8	1.9	0.1	2.0	1.3	0.4	1.3	1.0	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5
KERA	"CNA2, SLRR2B"	ENSG00000139330	Keratocan	O60938	12	91050491-91057983	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 10.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039321	Uncertain				"Secreted to extracellular matrix"					"HPA039321: AB_10795248"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.65e-1)"		"unprognostic (6.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.96e-2)"		"unprognostic (4.93e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.53e-1)"	0.8	0.0	0.2	1.9	0.2	0.0	2.9	0.0	0.2	1.9	2.5	0.0	0.0	0.0	1.0	2.5	1.5	2.2	4.3	0.4	0.1	0.0	0.0	0.0	0.6	0.2	0.5	0.0	0.6	0.0	0.0	0.0	1.5	0.2	0.5	0.3	0.0	2.8	0.2	4.7	0.2	0.9	0.4	0.0	0.0	1.3	0.2	0.0	0.3	0.1	10.9	0.5	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0
KLC3	"KLC2L, KLCt, KNS2B"	ENSG00000104892	"Kinesin light chain 3"	Q6P597	19	45333434-45351520	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 39.5;tongue: 25.3"	"Cell line enhanced"	"Detected in some"		"A-431: 25.2;HaCaT: 11.7;HBEC3-KT: 7.6;hTCEpi: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052797, HPA056508"	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA052797: AB_2681954, HPA056508: AB_2683159"	"unprognostic (4.11e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.07e-4)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (3.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.14e-1)"	"unprognostic (2.37e-1)"	0.1	0.2	0.0	0.2	1.2	1.9	1.9	0.0	0.5	4.0	0.1	0.0	0.0	0.1	0.6	2.9	10.6	0.1	0.2	0.1	0.2	0.0	1.9	0.1	0.7	0.2	0.0	0.0	0.3	4.5	1.5	1.1	0.9	0.5	1.7	0.2	4.0	7.8	2.2	0.6	39.5	0.3	0.0	0.0	0.2	0.2	2.8	0.2	0.3	1.1	25.3	9.2	0.2	7.9	1.5	1.0	3.3	0.9	1.0	1.3	0.6	25.2	0.2	0.1	0.3	0.1	0.1	2.1	0.2	0.0	0.0	0.1	2.5	4.7	0.2	2.1	0.0	11.7	1.6	7.6	0.1	0.6	3.8	0.1	0.7	0.5	0.0	0.2	1.6	0.0	9.5	0.1	1.8	0.0	0.4	0.3	0.1	3.3	0.1	0.3	0.6	0.8	4.0	0.0	0.2	0.2	0.9	3.4	0.5	0.2	5.4	0.7	4.7	0.1	0.0	0.3	2.7	0.2	0.3	0.6	0.5	0.2	0.1	0.1	0.3	3.3	0.7	0.6	0.8	0.5	0.7	0.9	1.0	0.9	0.3	1.5	1.0	1.3	2.6	1.0	0.9	1.0	0.8	0.6	0.0	1.2	0.0	0.5	0.2	0.0	0.0	0.0	0.5	0.2
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 52.5;HaCaT: 79.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	670000	670000				"prognostic favourable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.5	0.0	2.9	0.0	79.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	7	"A-431: 31.5;CAPAN-2: 41.3;HaCaT: 30.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	950000	950000	Vesicles	Vesicles	"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavourable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	41.3	0.0	0.8	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Group enriched"	"Detected in some"	100	"A-431: 211.8;HaCaT: 141.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		1100000000	1100000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in some"	7	"hTCEpi: 638.7;SiHa: 265.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		750000000	750000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favourable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	64.6	0.0	66.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	638.7	0.0	49.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	265.9	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Cell line enriched"	"Detected in some"	4	"BJ: 64.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		170000000	170000000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	64.5	2.8	7.7	15.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 118.0;HBEC3-KT: 211.3;hTCEpi: 483.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		6500000000	6500000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favourable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	118.0	0.0	211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	483.0	0.0	42.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavourable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell line enhanced"	"Detected in many"		"A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		290000000	290000000	"Intermediate filaments"	"Intermediate filaments"	"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavourable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.0	14.8	0.0	0.0	0.0	0.0	12.4	0.6	0.4	3.5	1.0	1.0	19.3	0.0	21.7	0.5	22.0	0.0	0.2	1.2	0.0	0.0	0.0	23.1	0.5	2.3	0.0	0.0	0.2	2.7	0.7	5.3	5.2	0.0	0.0	1.2	62.9	0.0	0.0	0.0	2.2	0.0	18.1	0.6	19.8	7.9	5.6	0.3	11.2	29.1	0.2	5.4	0.2	3.0	0.0	40.8	0.0	15.8	0.0	0.0	0.1	4.1	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KRTAP7-1	KAP7.1	ENSG00000274749	"Keratin associated protein 7-1 (gene/pseudogene)"	Q8IUC3	21	30829039-30829759	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.6;tongue: 3.1"	"Group enriched"	"Detected in some"	8	"SiHa: 3.3;SK-MEL-30: 2.0;WM-115: 2.6"	"Cancer enriched"	"Detected in single"	16	"urothelial cancer: 1.2"					"Cell type enriched"	"Detected in single"	13	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 2.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0										
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell line enriched"	"Detected in single"	55	"hTCEpi: 41.5"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	62000000	62000000			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134603138-134651636	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 19.5;tongue: 36.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.3;U-2197: 4.5;U-87 MG: 13.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.3	5.7	3.5	0.4	2.3	0.5	1.4	2.5	4.6	2.2	1.7	2.1	1.7	0.9	3.9	2.3	3.1	3.7	0.9	4.8	4.9	2.1	0.7	0.2	0.3	0.2	1.7	6.9	1.7	0.2	8.5	6.8	0.2	3.2	3.6	0.6	3.3	1.7	2.8	19.5	12.6	0.5	7.4	2.0	0.3	1.7	0.7	3.6	0.5	5.2	36.2	1.1	1.3	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	13.6	0.7	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.5	4.6	4.9	2.1	1.7	6.9	3.2	3.6
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"A-431: 37.3;CAPAN-2: 33.1;HaCaT: 48.1;HBEC3-KT: 36.6;hTCEpi: 35.6;MCF7: 40.9;RT4: 35.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"			"Actin filaments"	"Actin filaments"	"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	24.2	33.1	0.0	2.1	0.0	48.1	0.0	36.6	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	35.6	0.0	7.3	0.0	0.0	0.1	0.0	40.9	0.0	0.1	0.9	0.4	0.0	1.7	0.4	24.7	35.1	1.9	0.0	0.0	57.6	0.6	8.7	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5"	"Group enriched"	"Detected in some"	6	"hTCEpi: 8.5;hTERT-HME1: 7.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.3	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0.0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	7.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566772	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8"	"Cell line enriched"	"Detected in single"	6	"hTCEpi: 4.9"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.9	0.1	9.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	3.5	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	38.9	21.3	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 50.8;tongue: 90.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HAP1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 1.9"					"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		9700000	9700000	Nucleoplasm	Nucleoplasm	"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	6.5	9.2	4.8	3.4	6.2	3.5	12.0	11.0	7.2	6.9	11.5	2.7	2.4	5.0	4.2	6.4	12.7	3.5	4.9	8.1	4.6	5.0	5.6	4.8	18.0	2.9	3.8	3.9	5.7	5.5	10.0	6.3	5.3	4.3	8.2	6.1	14.7	6.4	3.9	30.7	50.8	13.4	5.2	2.8	4.0	4.4	4.0	1.2	0.8	3.1	90.3	13.6	5.1	6.2	0.3	0.1	4.1	0.3	0.0	1.9	3.8	5.7	3.6	10.4	24.4	0.3	0.1	3.1	1.6	3.9	3.1	2.9	17.0	1.2	0.0	2.4	0.8	6.8	35.6	6.6	2.5	6.4	9.3	0.1	1.8	8.3	3.1	1.6	2.4	1.5	4.2	1.3	4.7	1.9	0.0	1.7	0.0	4.4	2.3	0.3	8.1	4.3	2.6	6.4	1.8	3.6	4.1	1.7	6.9	5.1	3.5	3.0	2.4	0.2	0.8	2.0	6.2	1.3	3.0	7.3	3.4	4.8	0.0	1.0	2.6	0.0	0.3	3.7	0.0	0.0	1.9	0.3	0.4	0.4	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	3.8	4.8	6.2	11.0	7.2	4.6	5.0	3.8	3.9	4.3	1.2
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.3;U-266/70: 7.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	7.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106872-69123032	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 8.0"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036034	Uncertain									"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	4.8	1.9	0.1	0.0	28.3	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.9	0.0	0.0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1.0	0.2	0.2	0.1	0.9	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.6	0.0	0.2	0.7	8.0	0.0	0.1	0.1	0.0	0.1	0.6	1.7	0.1	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	1.0	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.0	0.1
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784880-142786592	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 236.9;skin 1: 111.6;tongue: 316.2"	"Cell line enriched"	"Detected in some"	20	"A-431: 55.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					92000	92000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	0.2	3.7	0.2	0.2	0.2	0.1	3.7	0.2	0.2	23.0	0.2	0.2	0.2	0.1	2.1	0.2	236.9	0.1	0.5	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	1.2	0.1	0.2	18.1	0.2	0.4	111.6	0.2	0.9	0.2	0.2	2.0	0.2	0.2	0.9	0.2	316.2	61.8	6.3	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		9700000	9700000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.0	0.1	0.0	0.2	0.1	0.0	4.6	0.4	1.1	0.4	0.5	0.1	12.5	0.0	0.5	0.3	29.4	0.0	1.3	0.2	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.1	0.0	0.1	0.0	0.0	0.0	0.0	32.8	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.3	31.5	0.0	0.0	0.1	47.3	0.5	5.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.9;skeletal muscle: 50.4;tongue: 28.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 17.0;LHCN-M2: 18.1;RH-30: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7"									"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavourable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	6.9	5.1	1.6	4.6	2.2	1.4	2.5	1.2	1.7	4.0	4.6	2.4	1.7	0.9	8.6	11.7	3.4	3.0	5.2	16.2	1.4	1.9	4.4	3.2	6.6	5.2	1.8	1.9	4.7	4.3	2.5	2.9	1.7	2.7	4.4	1.8	2.4	1.8	2.6	50.4	2.7	3.1	3.8	3.1	3.9	1.7	3.2	1.4	2.3	2.7	28.8	7.8	3.6	2.1	7.6	0.8	12.0	5.7	0.6	1.5	37.9	0.9	0.2	0.1	0.3	0.1	5.6	0.1	1.3	3.6	3.3	9.1	1.5	0.4	7.8	0.5	5.2	0.0	0.1	4.1	17.0	1.6	0.0	0.8	0.6	0.1	0.8	0.0	0.0	1.9	7.9	11.6	11.0	0.6	0.5	3.2	18.1	0.2	0.1	0.0	0.4	0.3	0.0	72.4	0.2	0.5	0.2	0.5	0.3	0.0	0.0	0.4	0.0	0.4	0.6	7.1	6.1	1.5	0.2	1.4	0.2	0.3	1.1	0.6	1.5	12.0	5.7	1.1	0.6	4.2	1.5	7.6	0.4	0.6	0.7	5.3	0.7	1.1	8.6	0.6	1.9	0.8	1.1	37.9	1.6	2.2	1.2	1.7	1.4	1.9	1.8	1.9	2.7	1.4
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705806	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 10.4;tongue: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"					"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				3.2	0.0	0.0	0.0	0.5	2.4	10.4	0.0	0.0	1.5	0.8	0.0	0.0	0.3	0.9	4.7	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	5.1	0.0	0.8	5.4	2.6	2.0	0.0	0.1	0.4	0.4	0.0	0.9	0.1	10.0	2.2	0.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRX3	MRGX3	ENSG00000179826	"MAS related GPR family member X3"	Q96LB0	11	18120955-18138480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.3;salivary gland: 7.9;tongue: 4.4"	"Cell line enriched"	"Detected in some"	10	"HBEC3-KT: 17.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"																				"unprognostic (1.54e-3)"	"unprognostic (5.07e-2)"			"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"		"unprognostic (7.65e-2)"	"unprognostic (1.74e-1)"					"unprognostic (4.75e-2)"	"unprognostic (2.09e-1)"			0.1	0.0	0.1	0.8	0.1	0.4	10.3	0.1	0.3	0.3	0.1	0.1	0.1	0.3	0.1	0.1	3.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	7.9	0.1	0.4	0.4	0.2	0.1	0.1	0.6	0.1	0.9	0.1	0.1	0.1	4.4	1.4	0.1	0.5	0.1	0.2	1.6	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.4	0.0	17.8	0.0	0.1	0.3	0.0	0.1	0.6	0.0	0.1	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.2	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.0	0.7	0.1	0.0	0.8	0.2	0.2	0.4	0.2	0.1	1.8	1.1	0.4	0.2	0.7	0.2	0.1	0.2	0.3	0.4	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.1;skeletal muscle: 59.2;tongue: 22.0"	"Cell line enriched"	"Detected in some"	10	"RH-30: 22.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"cerebellum: 24.2"	"Low region specificity"	"Detected in many"															"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.8	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	2.2	0.0	0.0	0.0		4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	4.4	0.0	0.9	0.4	0.0	1.2	0.1	0.0	59.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.9	22.0	0.7	0.0	0.0	2.5	1.7	4.2	1.4	1.7	2.4	0.4	0.0	0.8	0.4	0.9	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.7	0.5	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.7	0.2	1.9	0.3	0.1	0.0	1.0	1.8	0.0	0.6	0.0	0.0	0.1	1.3	0.0	2.1	0.0	0.9	0.2	1.5	0.5	22.2	0.0	0.0	0.1	0.6	0.2	0.3	0.1	0.1	0.4	0.7	0.0	0.3	0.8	0.8	0.6	1.1	0.1	0.1	0.4	0.3	0.0	4.2	1.4	1.6	2.4	1.0	1.7	2.0	1.7	1.5	1.2	2.5	1.2	2.1	4.2	1.7	1.0	1.7	1.5	0.4										
MSGN1	pMesogenin1	ENSG00000151379	"Mesogenin 1"	A6NI15	2	17816496-17817101	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.2;esophagus: 2.9;tongue: 2.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.3;REH: 1.1;RH-30: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.0;hippocampal formation: 2.2"	"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (3.63e-2)"				"unprognostic (3.25e-2)"									"unprognostic (1.66e-1)"			0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	2.9	0.6	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.1	0.0	1.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.1	0.4	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.0	2.2	0.1	0.0	0.0	0.4	0.0
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055697-190062729	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.2;tongue: 15.8"	"Group enriched"	"Detected in some"	12	"LHCN-M2: 15.9;RH-30: 32.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	4800000	4800000			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	3.3	1.9	1.7	0.7	1.4	0.2	0.8	4.1	1.8	4.8	1.1	2.2	0.0	0.7	1.8	1.2	2.3	0.5	0.6	0.7	3.5	1.6	1.1	0.3	0.3	0.3	1.3	0.0	0.7	0.4	0.4	1.4	0.2	3.4	1.0	1.1	0.9	1.0	0.5	17.2	1.2	2.1	0.9	1.1	0.3	0.6	0.7	4.0	0.0	0.7	15.8	0.4	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	4.1	1.0	3.5	1.6	1.3	0.0	3.4	4.0
MTRNR2L5		ENSG00000249860	"MT-RNR2-like 5"	P0CJ72	10	55599303-55600041	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"														"Secreted - unknown location"															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0.0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1.0	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0.0	4.7	7.0	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0.0	0.4	6.6	0.3	1.0	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0.0	0.3	0.3	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.4	0.0	0.9	0.4	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0.0	0.1	1.5	2.5	0.4	2.3	1.0	0.5	1.4	0.6	0.6	0.9
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3"	"Cell line enhanced"	"Detected in some"		"BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	4.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	23.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.1	2.1	0.0	114.9	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.9	46.3	3.4	0.0	0.0	0.3	0.1	3.8	0.1	0.2	0.1	0.0	1.1	0.5	0.0	0.0	0.3	1.7	0.0	16.3	8.2	6.1	2.3	0.0	0.0	0.0	0.0	45.8	0.3	0.0	0.1	10.8	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.8	0.0	3.3	0.3	0.1	0.0	0.1	19.7	3.4	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.0	1.7	3.8	0.1	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		35000	35000	Mitochondria	Mitochondria	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favourable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.0	12.0	1.3	9.6	4.1	4.8	1.9	5.4	6.3	2.7	4.7	0.6	10.1	7.3	16.7	6.9	10.2	3.7	3.1	0.9	9.4	3.9	9.6	4.1	6.5	6.3	3.3	5.6	5.3	13.0	3.5	6.9	5.5	0.1	4.9	2.8	10.8	5.6	8.1	5.9	6.8	11.1	1.6	2.4	6.5	5.2	1.8	6.3	8.0	4.3	3.5	13.9	9.9	6.4	5.4	4.9	4.8	2.8	1.7	1.9	2.4	0.8	10.3	3.8	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 79.5;K-562: 62.4;Karpas-707: 28.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in single"			HPA025926	Uncertain				"Secreted in other tissues"					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.3	0.0	4.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	12.8	18.4	1.8	0.0	79.5	9.6	0.7	0.5	1.1	5.2	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	62.4	28.7	0.0	2.0	0.2	0.0	2.4	2.4	0.0	0.0	0.1	0.4	0.0	4.1	10.4	6.4	0.1	0.0	4.4	0.0	0.5	0.0	6.0	0.0	11.1	8.3	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 19.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050283, HPA054158"	Supported									"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	19.9	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439458-23442390	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.8;tongue: 61.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.7;HaCaT: 23.3;SiHa: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	11.6	9.2	5.9	8.5	6.9	39.3	14.7	9.7	9.5	13.8	8.8	9.3	6.9	4.9	9.8	10.0	8.2	9.0	9.9	25.9	6.0	5.9	14.7	7.3	26.6	11.0	6.2	6.7	10.9	6.5	12.8	7.8	11.5	5.4	8.0	5.8	9.8	6.4	6.2	60.8	17.5	7.9	7.3	6.5	13.1	16.9	9.9	5.8	8.1	14.9	61.1	12.3	12.7	10.5	3.5	1.0	5.1	4.0	0.2	3.5	0.5	2.9	1.4	1.6	0.7	6.3	3.2	2.0	1.2	2.7	2.9	2.6	0.6	24.7	1.4	2.6	1.5	23.3	1.7	2.9	1.9	10.5	4.5	0.0	3.6	0.9	5.4	0.2	2.0	3.2	12.9	0.8	4.1	0.9	0.3	9.9	1.6	1.4	0.9	0.9	1.2	0.8	1.5	7.1	1.3	3.8	2.6	0.7	1.7	15.1	2.7	6.8	1.1	2.1	1.7	1.6	2.4	4.5	0.5	4.8	9.0	0.7	2.5	0.9	0.6	5.1	1.6	2.6	0.8	1.7	1.0	1.9	1.5	0.8	1.0	3.5	1.2	1.7	3.6	0.2	4.0	0.6	3.5	0.5	5.9	6.9	9.7	9.5	6.0	5.9	6.2	6.7	5.4	5.8
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787022-65797219	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;tongue: 37.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.9;BEWO: 28.5;CACO-2: 7.2;HaCaT: 16.8;RT4: 16.6;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003984	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.2	0.1	0.2	3.3	0.3	0.0	2.2	0.4	0.2	7.2	11.5	0.0	3.0	9.6	0.4	0.7	42.6	0.3	4.2	0.1	0.2	0.2	4.7	0.2	1.7	0.0	0.2	0.0	0.1	5.6	5.0	0.2	14.4	0.0	2.3	5.1	1.1	13.9	6.1	0.5	24.1	14.2	0.8	0.2	0.2	0.8	17.3	0.0	0.6	1.8	37.4	25.3	8.3	9.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	7.2	2.7	0.0	0.1	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	16.6	0.1	0.0	0.0	13.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18631006-18748866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.9;tongue: 12.0"	"Group enriched"	"Detected in some"	7	"A549: 3.4;CAPAN-2: 3.7;U-2 OS: 8.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"midbrain: 5.5"	"Low region specificity"	"Detected in some"														"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.4	0.1	0.6	0.0	0.6	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.5	0.1	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	3.4	0.3	0.0	0.0	0.1	0.1	12.9	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	3.4	0.8	0.8	2.4	0.0	3.4	0.0
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 28.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.9;Hep G2: 3.9;U-87 MG: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA048975	Approved									"HPA048975: AB_2680581"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	2.0	1.3	1.8	1.5	2.8	1.0	2.0	0.8	6.1	4.1	4.4	1.5	3.1	1.5	6.4	6.8	1.3	4.2	5.6	4.2	1.6	1.9	4.1	2.0	4.1	0.5	1.7	5.1	2.0	0.8	0.3	3.5	7.0	2.8	5.8	1.3	2.5	1.3	5.4	13.4	0.6	4.1	3.4	0.7	2.3	5.2	2.6	1.1	0.4	1.2	28.6	0.7	1.8	3.3	1.3	0.6	3.5	0.7	1.0	0.7	0.2	0.1	0.3	0.2	0.3	0.1	0.3	5.9	0.1	0.0	0.2	0.3	1.2	0.2	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	3.9	0.2	0.2	0.5	0.7	0.1	2.5	0.0	0.0	0.9	2.0	0.1	0.4	0.2	0.3	0.1	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.8	0.3	0.5	0.0	0.5	0.3	0.0	0.4	0.2	0.7	0.1	1.3	0.6	0.2	8.8	0.2	0.3	3.4	0.7	1.0	0.6	0.4	0.5	0.5	0.5	0.4	0.2	1.3	0.5	0.7	3.5	1.0	0.4	0.6	0.3	0.2	1.8	2.8	0.8	6.1	1.6	1.9	1.7	5.1	2.8	1.1
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.2;hTCEpi: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022269	Enhanced									"HPA022269: AB_1855219"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.0	11.3	0.0	1.1	7.9	8.4	23.6	16.4	18.5	2.3	1.7	9.2	20.8	0.0	5.9	4.1	37.2	2.0	29.6	0.5	15.8	9.2	0.0	11.3	8.7	5.7	0.0	0.0	6.3	139.5	0.2	15.2	9.2	0.1	4.4	0.2	6.9	0.0	0.5	4.8	6.0	0.0	3.7	0.0	15.8	11.7	3.9	0.0	17.3	9.3	7.9	5.2	2.0	11.0	4.1	1.6	4.4	0.0	1.3	1.7	0.0	3.3	0.0	8.7	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	2100000	2100000	"Plasma membrane"	"Plasma membrane"	"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.6;HeLa: 32.4;K-562: 31.6;T-47d: 47.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	16.9	10.4	0.0	14.0	0.5	0.2	4.3	3.4	4.9	1.6	0.6	39.6	10.0	19.0	5.4	0.2	5.7	2.3	8.1	0.1	0.2	14.8	4.7	32.4	10.9	5.1	1.7	0.0	0.4	5.9	0.0	1.9	0.0	31.6	0.0	0.5	5.2	0.1	3.8	0.0	9.3	5.6	0.3	0.3	0.2	5.3	6.5	0.0	14.8	8.0	0.0	47.1	1.1	0.6	1.8	4.7	1.0	5.2	0.0	0.0	12.5	2.4	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0
PITX3	ASMD	ENSG00000107859	"Paired like homeodomain 3"	O75364	10	102230186-102241474	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 19.9;tongue: 13.7"	"Cell line enriched"	"Detected in some"	16	"RH-30: 25.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"midbrain: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.3"	"Region enriched"	"Detected in single"	5	"midbrain: 13.2"												"unprognostic (8.13e-2)"	"unprognostic (4.07e-1)"		"unprognostic (5.15e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"		"unprognostic (6.04e-5)"	"unprognostic (6.30e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.36e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.13e-2)"	1.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	13.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	25.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Group enriched"	"Detected in some"	8	"T-47d: 6.3;U-266/70: 16.7;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain									"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	6.3	0.0	0.0	0.0	0.9	0.0	0.0	16.7	6.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in some"	5	"HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		2700000	2700000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	44.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.0	1.0	25.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Group enriched"	"Detected in some"	5	"AF22: 13.9;AN3-CA: 14.0;NTERA-2: 7.1;SCLC-21H: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favourable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	14.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.9	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"																						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.6	1.7	0.2	0.4	2.1	1.0	4.1	1.0	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell line enhanced"	"Detected in many"		"A-431: 11.1;HaCaT: 19.5;SK-BR-3: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.1	1.2	0.0	0.7	0.0	0.5	1.9	5.2	1.3	3.4	0.8	1.5	8.6	0.0	2.5	2.1	19.5	0.2	3.2	0.5	3.8	0.8	0.0	3.4	2.2	0.4	0.2	0.1	0.1	2.7	2.2	1.2	0.3	0.2	3.1	0.2	6.5	0.0	0.2	0.3	9.0	0.0	0.0	4.1	3.6	3.4	0.1	0.1	5.8	13.3	0.7	2.5	0.0	2.3	4.2	1.8	0.4	3.4	2.5	0.1	0.1	5.1	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.8	2.5	0.0	0.0	18.3	26.6	8.8	0.0	0.4	0.0	0.1	11.3	17.4	0.1	4.0	0.3	55.8	0.3	6.7	0.0	0.0	0.3	0.0	13.5	2.0	1.1	0.0	0.0	1.3	6.2	0.0	2.1	0.0	0.0	0.0	0.0	20.4	0.0	0.0	1.7	5.3	0.0	0.0	8.6	13.3	10.9	9.2	0.1	29.9	10.0	0.1	5.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.4;RT4: 5.8;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	13.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;SK-BR-3: 21.8;T-47d: 12.8;U-266/70: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"			Vesicles	Vesicles	"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.4	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.9	1.3	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.6	0.0	21.8	0.5	12.8	1.5	0.0	0.3	0.0	0.0	0.0	4.5	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137536-31139350	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;HaCaT: 1.6;SiHa: 1.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061228	Enhanced				"Secreted in other tissues"					"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	58.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	13.8	0.0	35.9	0.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113242-88175467	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.5;tongue: 38.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 18.9;hTCEpi: 68.0;hTERT-HME1: 60.6;SK-MEL-30: 36.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Region enriched"	"Detected in single"	5	"pons and medulla: 3.2"	"Group enriched"	"Detected in many"	5	"NK-cell: 15.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.2;NK-cells: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA071701			Uncertain	"Nuclear bodies,Mitochondria"				"Nuclear bodies, Mitochondria"	"Nuclear bodies, Mitochondria"	"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favourable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	1.8	15.6	0.4	1.2	0.4	0.4	4.6	0.3	0.6	10.8	1.6	1.2	2.8	1.0	7.0	8.7	29.9	2.8	8.2	1.7	0.6	0.5	2.6	0.8	5.3	0.4	0.5	0.2	3.0	2.3	0.9	4.6	7.7	3.2	4.0	0.4	35.5	4.9	5.2	0.5	24.9	2.4	2.7	0.7	1.3	0.9	5.3	0.1	1.6	6.6	38.1	21.0	4.2	13.3	0.0	4.2	0.5	1.3	15.3	1.8	0.6	2.2	0.3	0.0	0.1	0.0	0.5	0.1	1.4	5.7	2.3	4.2	1.0	1.0	0.1	1.4	1.5	15.6	1.2	18.9	3.1	0.2	1.1	11.4	1.5	0.0	0.2	0.1	0.1	0.5	68.0	0.3	60.6	2.7	0.0	0.2	0.0	0.0	0.1	3.8	1.8	0.0	0.1	0.0	0.1	4.4	8.7	0.4	0.2	0.0	0.0	36.6	3.4	1.0	1.5	0.0	1.0	0.0	0.2	0.3	1.4	0.0	0.3	0.4	0.2	0.0	0.6	0.1	1.6	0.6	0.9	0.0	0.5	1.8	1.5	0.0	0.1	0.9	0.5	15.3	1.3	4.2	0.9	0.6	0.4	0.4	0.3	0.6	0.6	0.5	0.5	0.2	3.2	0.1
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Focal adhesion sites"	"Focal adhesion sites"	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.1	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.0	1.6	0.0	15.5	0.2	0.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.3	15.5	0.9	3.2	0.1	0.0	1.3	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.4	2.0	0.0	1.1	0.0	2.9	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.7	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.9;hTCEpi: 18.3;SiHa: 9.0;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062673			Supported	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.7	0.0	0.6	2.4	1.0	1.5	0.0	1.2	0.0	0.4	1.3	2.0	0.7	4.0	0.8	0.2	1.2	0.4	22.9	0.0	0.5	0.0	0.0	2.6	18.3	2.8	1.3	0.4	0.2	0.1	0.4	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.8	2.4	0.3	0.2	9.0	0.3	0.0	0.3	0.2	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavourable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0	0.3	0.0	31.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.5	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.1	15.3	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.8	0.0	19.3	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	5.9	0.0	0.0	0.0	0.0	9.0	3.3	6.1	6.5	0.0	0.5	0.0	2.8	6.4	0.0	5.6	0.2	11.1	0.0	0.2	0.0	0.5	3.0	0.2	0.0	0.5	3.2	0.0	1.2	0.2	0.7	0.0	0.0	28.6	1.3	0.0	0.0	2.0	0.7	0.0	29.5	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	13.8	0.2	0.0	2.1	4.9	0.0	7.7	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;hTCEpi: 4.4;RT4: 4.4;SK-MEL-30: 2.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced									"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	4.4	0.3	0.3	0.8	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874289	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 74.8;skin 1: 31.5;tongue: 29.2"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 82.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA053343	Enhanced									"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.2	0.0	0.4	0.4	0.4	0.0	7.8	0.8	0.9	8.8	0.9	0.2	0.5	0.1	0.6	4.8	74.8	1.2	0.6	0.2	0.4	0.3	1.9	0.2	1.9	0.2	0.2	0.5	0.2	7.4	0.4	0.7	7.3	1.2	4.2	1.1	0.2	12.6	1.1	0.2	31.5	0.5	0.7	0.3	0.3	0.3	0.8	0.3	2.0	0.2	29.2	27.9	5.2	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.0	0.9	1.1	0.0	0.6	0.0	19.3	1.1	0.1	0.0	2.5	3.1	0.1	2.7	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.1	0.0	6.5	0.1	0.5	0.4	0.9	0.9	0.1	0.4	1.2	8.4	1.0	0.2	1.9	82.5	0.0	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.8	0.9	0.4	0.3	0.2	0.5	1.2	0.3
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042226-21044234	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.0;hTCEpi: 6.5;hTERT-HME1: 32.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"					"CAB062560: AB_2665595, CAB068225: , HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.3	38.3	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.5	0.2	0.0	3.5	0.2	0.2	14.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	21.4	41.0	0.6	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNF222		ENSG00000189051	"Ring finger protein 222"	A6NCQ9	17	8390704-8397826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 12.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048916	Uncertain									"HPA048916: AB_2680555"	"unprognostic (2.49e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.19e-4)"	"unprognostic (2.81e-1)"	"unprognostic (5.30e-2)"		"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.97e-2)"	0.1	0.0	0.1	0.1	0.1	1.8	0.5	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.6	0.1	15.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	1.8	0.1	0.1	6.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.6	9.4	0.1	5.5	0.4	0.5	2.0	0.5	0.2	1.0	0.1	1.1	0.0	0.0	0.2	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	12.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.6	0.5	1.0	0.3	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.6	1.0	2.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RNF223		ENSG00000237330	"Ring finger protein 223"	E7ERA6	1	1070966-1074307	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"A-431: 11.7;CAPAN-2: 8.8;HaCaT: 5.5;MCF7: 18.7;SK-BR-3: 12.8;T-47d: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (4.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (3.50e-1)"	"unprognostic (6.50e-2)"		"unprognostic (1.43e-3)"	"unprognostic (3.91e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-1)"	"unprognostic (9.52e-3)"	0.0	0.0	0.0	1.4	0.0	0.4	0.8	0.0	0.5	8.3	1.4	0.0	0.0	0.4	1.0	0.3	28.8	0.2	1.9	0.0	0.0	0.0	0.6	0.3	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	6.5	0.0	4.2	0.8	0.0	3.3	0.4	0.7	3.5	0.2	2.6	0.0	0.2	7.8	0.1	0.0	0.0	0.2	14.8	17.1	4.9	9.3	0.6	0.6	1.9	0.4	0.3	0.4	0.0	11.7	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	18.7	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	12.8	0.2	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.4	0.0	0.6	0.2	0.4	0.9	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF225		ENSG00000269855	"Ring finger protein 225"	M0QZC1	19	58396090-58397079	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.6;lymphoid tissue: 16.5;tongue: 21.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SCLC-21H: 1.1;T-47d: 3.2;U-266/84: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (3.07e-1)"	"unprognostic (6.94e-2)"				"unprognostic (3.68e-3)"		"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.75e-3)"		"unprognostic (1.40e-1)"		"unprognostic (3.42e-1)"	"unprognostic (9.18e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.0	0.0	0.0	3.1	0.0	0.0	0.1	31.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	1.4	0.0	0.0	1.9	2.1	0.0	6.2	0.0	0.4	0.0	0.1	0.1	1.1	0.0	0.0	0.2	21.8	16.5	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	0.9	1.1	0.3	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.6;Karpas-707: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049136	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	1.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	1.4	0.0	0.1	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.8	0.0	148.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	36.7	2.1	0.0	0.0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.4	0.5	2.3	0.1	0.1	1.4	0.9	0.0	0.1	0.0	7.6	4.1	1.3	1.4	0.0	2.1	0.2	0.2	0.0	1.0	1.2	0.8	1.7	2.6	0.0	0.5	0.9	0.2	0.3	0.2	0.2	0.0	0.8	5.6	0.1	1.2	1.6	1.9	1.3	4.9	0.7	0.7	1.7	0.3	0.8	3.3	1.0	1.0	2.7	1.2	1.4	1.1	1.1	1.1	2.8	1.6	0.8	2.5	1.1	1.1	1.6	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1.0	1.7	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Group enriched"	"Detected in some"	10	"A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		110000	110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"	"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.8	11.4	0.0	0.1	0.0	86.8	0.0	123.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	183.4	0.0	1.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	4.1	0.0	0.0	0.1	129.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 118.0;SK-BR-3: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		92000	92000	Cytosol	Cytosol	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (3.18e-4)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.5	27.2	1.4	3.2	9.4	35.7	3.7	32.4	29.8	26.6	23.7	25.5	31.6	0.0	52.0	48.4	41.5	0.0	72.6	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	118.0	0.7	0.0	58.5	75.0	0.0	0.1	6.0	73.7	0.0	16.4	0.1	100.3	20.3	0.0	0.1	23.8	143.0	4.7	44.4	0.3	63.3	16.0	25.7	15.4	73.1	0.0	0.2	0.1	47.6	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.3;SK-BR-3: 16.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	17000000	17000000	Cytosol	Cytosol	"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	7.3	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.8	16.9	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	530000000	530000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	1400000000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"	"Nucleoplasm, Cell Junctions, Cytosol"	"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.7;ASC TERT1: 34.4;HSkMC: 46.5;U-2197: 16.0;U-87 MG: 37.7"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	62000000	62000000	Vesicles	Vesicles	"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.7	34.4	0.0	1.5	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.5	2.5	9.3	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	5.8	1.2	16.0	0.4	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced									"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favourable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	9.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.4	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923154-56934405	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 31.4;tongue: 27.8"	"Group enriched"	"Detected in some"	6	"hTCEpi: 1.1;SK-BR-3: 4.3"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.1	9.6	0.1	0.1	0.1	0.0	0.7	0.1	8.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.1	2.0	0.1	0.5	31.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	0.1	27.8	9.9	0.1	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.3	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722641-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 50.0"	"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002143	Enhanced					640000000	640000000			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	14.9	2.7	0.9	30.4	1.2	0.2	8.3	0.3	1.0	13.7	2.7	1.9	4.4	0.4	18.1	3.2	6.7	20.1	7.4	4.4	0.9	0.9	2.5	4.9	10.6	2.0	1.2	0.0	9.8	1.4	21.0	3.1	0.9	5.4	21.2	1.9	4.3	2.0	4.6	2.2	3.7	2.4	13.1	4.8	0.2	3.4	5.6	0.5	0.9	9.0	50.0	15.5	16.4	4.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.9	1.2	0.3	1.0	0.9	0.9	1.2	0.0	5.4	0.5
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	660000	660000	Vesicles	Vesicles	"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavourable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavourable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	143.8	0.0	47.4	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	99.9	0.0	25.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	10.5	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Cell line enhanced"	"Detected in some"		"BJ: 45.7;fHDF/TERT166: 32.2;HaCaT: 78.8;HBEC3-KT: 25.0;HBF TERT88: 43.8;hTERT-HME1: 25.5;U-138 MG: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.7	0.0	45.7	9.2	7.0	5.2	0.0	0.2	0.0	0.0	32.2	78.8	0.0	25.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.5	1.0	25.5	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	1.6	0.9	4.3	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"	54000000	54000000	Cytosol	Cytosol	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced									"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.6	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.4	0.0	0.2	0.7	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	2.3	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	5.9	0.9	1.0	0.9	5.5	0.1	0.0	6.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.1	1.2	3.4	0.5	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769844	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8"	"Cell line enriched"	"Detected in some"	4	"HaCaT: 24.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	112.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	105.8	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	5.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	28000000	28000000	Vesicles	Vesicles	"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Group enriched"	"Detected in some"	84	"HeLa: 239.2;SiHa: 114.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011039	Uncertain				"Secreted - unknown location"					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favourable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	239.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor, Kazal type 7 (putative)"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 161.8;tongue: 124.0;vagina: 79.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.9;HeLa: 2.1;hTCEpi: 3.9;PC-3: 3.1;SiHa: 1.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted - unknown location"	90000	90000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	39.1	0.1	0.0	0.0	0.1	2.8	0.1	161.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	16.9	0.1	0.2	1.1	0.1	0.1	0.0	0.1	1.3	0.1	0.0	0.6	0.1	124.0	30.6	0.2	79.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR1B	"GADD33, SPRR1"	ENSG00000169469	"Small proline rich protein 1B"	P22528	1	153031202-153032900	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5"	"Cell line enriched"	"Detected in some"	9	"hTCEpi: 89.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.73e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.59e-2)"		"unprognostic (9.68e-2)"		"prognostic unfavourable (7.66e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (7.64e-5)"			"unprognostic (5.71e-2)"		"unprognostic (2.15e-1)"	"prognostic unfavourable (7.28e-4)"	0.1	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	94.9	0.1	0.1	0.1	0.1	9.5	0.2	264.7	0.2	2.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	48.7	0.1	0.2	33.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.9	0.1	618.5	188.6	0.2	113.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	9.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	89.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR2E		ENSG00000203785	"Small proline rich protein 2E"	P22531	1	153093135-153106184	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 210.2;skin 1: 94.0;tongue: 291.9"	"Cell line enriched"	"Detected in some"	11	"hTCEpi: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 612.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (2.27e-1)"				"unprognostic (3.86e-2)"		"unprognostic (5.04e-2)"	"unprognostic (3.40e-1)"								"prognostic unfavourable (9.47e-4)"	0.3	0.0	0.3	0.3	0.3	0.0	5.7	0.3	0.3	25.9	0.3	0.3	0.3	0.0	0.6	0.3	210.2	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	26.8	0.3	0.3	94.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.4	0.3	291.9	54.7	0.3	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;hTCEpi: 10.9;RT4: 13.9;TIME: 3.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 423.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044467	Enhanced					15000	15000			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavourable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	157.6	0.2	0.0	0.0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	1.2	0.0	0.2	0.2	0.0	93.4	0.2	0.4	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.2	389.6	537.4	0.6	163.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	6.7	3.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	10.9	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	13.9	0.0	0.0	0.4	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.1;U-2197: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Plasma membrane"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.3	7.5	3.4	1.2	9.9	26.6	5.5	2.8	6.7	1.1	1.1	8.8	17.2	0.0	12.3	1.1	40.1	1.9	6.6	1.1	0.2	3.7	0.0	9.5	5.7	6.0	1.5	0.3	24.4	6.5	12.4	4.5	19.9	0.0	0.1	1.7	5.4	1.4	0.8	1.7	2.7	3.2	10.1	0.1	11.8	5.8	4.1	3.4	2.5	0.3	8.8	3.1	1.8	12.8	5.7	5.9	28.1	8.4	0.1	0.0	0.0	22.0	3.4	19.5	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5
TBX15	TBX14	ENSG00000092607	"T-box 15"	Q96SF7	1	118883046-118989556	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.3;skeletal muscle: 84.9;tongue: 37.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052245, HPA053713"	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA052245: AB_2681771, HPA053713: "	"unprognostic (1.94e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.72e-3)"	"unprognostic (7.79e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (5.57e-8)"	"unprognostic (2.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.31e-1)"	18.1	0.1	0.2	0.1	0.5	0.1	12.5	0.4	0.8	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.2	0.1	0.3	1.2	0.5	0.0	0.1	23.3	0.2	1.3	0.2	0.2	0.1	0.1	0.2	0.5	0.1	2.1	0.7	0.0	0.2	2.8	0.1	84.9	3.6	0.1	0.2	0.6	0.0	0.1	0.4	0.4	0.0	1.9	37.5	2.4	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	27.7	11.7	0.0	2.4	3.2	6.3	10.6	0.0	0.0	0.0	1.3	14.1	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	19.9	0.1	0.1	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.1	1.2	0.1	0.0	14.9	0.2	1.5	0.7	0.3	0.0	0.8	0.0	0.3	0.0	0.3	0.0	3.4	2.1	14.0	0.1	0.2	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.8	0.5	0.0	0.2	0.2	2.1	0.4
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell line enriched"	"Detected in some"	7	"HEL: 19.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"														"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575482-89631056	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.9	0.4	0.3	3.5	0.4	6.9	0.6	0.1	0.4	1.0	2.5	0.1	0.1	2.2	1.0	0.1	9.0	0.7	0.5	0.3	0.2	0.3	0.3	0.2	0.7	2.9	0.4	0.1	0.9	0.1	0.0	0.3	3.9	0.1	0.5	2.6	0.2	1.2	0.1	0.1	1.0	3.2	0.4	0.2	2.9	0.9	7.7	0.1	21.7	0.4	9.5	12.2	0.8	2.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	7.0	9.7	12.6	7.2	0.5	1.0	7.1	5.2	2.4	7.3	7.7	10.5	5.5	9.4	2.8	1.7	14.1	17.3	4.6	6.7	4.7	16.6	14.0	9.4	5.5	0.0	9.9	5.1	0.3	0.3	6.0	4.4	3.6	13.3	11.0	4.2	6.6	8.7	8.4	8.4	5.0	12.5	11.4	7.5	1.7	10.0	5.4	5.3	12.3	7.0	2.1	5.2	6.7	2.1	8.0	10.0	16.2	10.5	2.6	4.9	8.1	2.7	8.5	4.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.4	0.1	0.3	0.2	0.3	0.4	0.1	0.1	0.1
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced									"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (6.87e-4)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.1	54.2	10.8	13.6	1.0	4.3	7.1	32.4	17.0	48.2	66.9	47.8	27.5	21.2	11.4	19.4	29.7	9.8	28.9	25.0	7.3	36.2	37.4	19.4	31.3	0.3	15.8	24.2	2.1	0.9	25.1	3.4	19.6	23.0	47.0	18.5	48.7	7.9	8.9	5.6	37.8	21.4	43.8	47.3	12.8	21.2	4.9	14.3	24.8	68.2	9.1	46.0	21.3	9.0	47.4	46.6	33.8	41.6	19.8	10.3	27.3	23.3	10.7	21.3	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 72.0;hTCEpi: 16.2;hTERT-HME1: 20.5;RT4: 10.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044165	Enhanced		Approved	Cytosol		7000000	7000000	Cytosol	Cytosol	"HPA044165: AB_10961279"	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.2	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	2.1	0.0	72.0	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.0	20.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.1	0.0	0.0	0.0	9.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 47.5;skin 1: 35.7;tongue: 37.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.5;SK-BR-3: 17.8;T-47d: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	1.2	1.3	2.4	1.2	5.1	2.0	3.4	3.4	3.7	12.5	1.2	3.6	1.9	1.8	1.3	1.9	47.5	1.5	1.9	1.0	2.0	1.1	1.1	1.4	1.0	1.8	5.6	1.4	1.5	1.0	3.8	2.5	4.5	3.1	19.0	1.1	1.2	9.4	2.1	1.9	35.7	1.3	1.1	3.2	1.6	1.6	0.9	5.2	3.7	1.5	37.2	24.2	3.3	20.5	5.2	4.1	7.8	4.1	3.0	5.2	3.1	8.0	4.8	1.7	3.1	1.2	1.3	4.0	2.4	0.9	4.3	1.7	5.6	2.3	1.5	5.2	0.6	7.2	1.8	3.6	1.8	5.4	2.7	1.5	1.9	1.6	2.3	1.6	2.3	1.3	21.5	3.2	3.3	0.9	6.8	10.1	2.0	9.6	4.7	2.6	2.5	3.8	5.6	1.6	3.2	0.8	2.5	2.9	3.2	2.9	17.8	4.6	19.0	4.9	2.3	8.0	2.7	2.8	6.2	7.8	8.2	3.4	5.5	4.0	6.0	0.0	4.1	5.6	3.9	1.4	3.9	3.7	3.4	4.0	3.2	5.2	4.4	5.2	7.8	3.0	2.6	4.1	4.0	3.1	2.4	5.1	3.4	3.7	2.0	1.1	5.6	1.4	3.1	5.2
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11B		ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245720	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.24e-2)"				"prognostic favourable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	11.2	0.1	0.0	0.0	0.1	0.5	0.1	138.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	13.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	44.0	57.0	0.1	23.2	0.7	0.6	2.4	0.5	0.4	0.7	0.0	0.3	1.4	0.8	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.8	0.4	1.3	0.1	0.4	1.0	0.2	0.1	0.0	0.1	1.5	0.8	1.8	2.0	0.1	1.1	1.3	0.5	0.2	0.0	0.1	0.0	0.7	2.0	0.1	0.7	0.5	1.3	0.1	1.0	0.6	0.6	0.5	0.2	1.4	0.8	0.3	0.1	0.2	0.1	0.4	0.2	1.3	1.0	0.3	0.5	0.1	0.2	0.9	0.7	0.3	1.0	0.1	0.3	0.4	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.0	0.7	0.3	0.7	2.4	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.8;HBEC3-KT: 2.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavourable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	5.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Group enriched"	"Detected in some"	8	"HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026911	Uncertain									"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF18	"AITRL, hGITRL, TL6"	ENSG00000120337	"TNF superfamily member 18"	Q9UNG2	1	173039960-173050963	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;tongue: 9.9"	"Group enriched"	"Detected in some"	11	"EFO-21: 20.6;HUVEC TERT2: 30.9;TIME: 42.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hippocampal formation: 7.3"	"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"					"Low region specificity"	"Detected in many"														"unprognostic (2.78e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.71e-4)"	"unprognostic (8.42e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.74e-2)"	0.9	0.4	0.4	0.3	0.8	0.0	0.4	1.1	4.6	0.4	0.4	3.2	0.0	1.1	0.3	0.0	3.6	0.3	5.0	1.5	7.3	0.4	0.7	1.9	1.0	0.2	0.4	1.0	0.3	0.3	2.2	0.7	1.3	1.4	0.4	1.0	0.2	0.3	0.0	0.3	0.4	3.5	0.1	0.6	0.6	0.4	0.3	0.0	0.0	0.7	9.9	1.4	0.6	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.2	0.0	0.0	0.0	0.0	20.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.7	30.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.4	0.8	1.1	2.4	7.3	0.4	0.4	1.0	1.4	0.0
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5"	"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SK-BR-3: 2.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"									"HPA044300, HPA048797"	Uncertain									"HPA044300: AB_2678888, HPA048797: AB_2680524"	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	0.3	4.6	0.1	0.2	4.2	0.0	0.4	8.9	19.6	3.2	0.1	0.1	0.3	0.6	0.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	1.2	0.1	0.1	3.0	1.2	0.9	22.5	0.2	0.1	0.1	0.1	0.2	0.6	0.1	15.2	0.1	31.5	6.7	0.2	11.0	0.4	0.1	1.9	0.2	0.2	0.3	0.1	0.4	0.0	0.2	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.4	0.4	0.5	0.0	0.1	1.6	0.0	0.1	1.0	0.0	0.8	0.6	0.0	0.4	0.0	0.0	3.4	1.1	0.1	0.0	2.3	0.0	0.7	0.0	0.0	0.7	0.7	0.5	0.4	0.0	0.0	0.4	0.0	0.2	0.1	1.3	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	1.9	0.2	0.1	0.1	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.1	0.1	0.1
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 1091.5;tongue: 332.2"	"Cell line enhanced"	"Detected in many"		"BJ: 197.7;fHDF/TERT166: 107.9;HSkMC: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	727	"plasmacytoid DC: 76.4"	"Lineage enriched"	"Detected in single"	727	"dendritic cells: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047089, HPA053624"	Approved					290000000	290000000			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	14.5	8.2	1.8	24.5	1.6	0.7	9.1	3.7	1.7	47.5	101.0	1.4	76.0	8.4	86.6	51.1	166.5	26.8	100.3	34.6	1.9	1.4	9.5	1.1	10.0	5.3	1.5	3.1	29.2	2.2	1.1	2.6	8.6	3.4	72.2	9.6	15.0	21.0	81.0	1091.5	4.2	27.4	231.7	1.6	4.7	48.7	13.4	0.6	0.2	9.3	332.2	22.0	190.7	38.6	0.0	76.4	0.1	0.0	0.0	0.0	0.4	29.9	22.9	16.1	2.6	30.4	81.4	9.9	197.7	80.6	83.7	56.9	0.9	1.9	0.0	17.7	107.9	0.6	0.2	24.4	38.8	55.2	0.7	0.7	81.8	0.9	48.5	0.1	8.1	94.9	3.8	62.7	0.0	19.6	0.3	0.0	84.2	1.1	0.1	2.0	20.4	1.3	1.3	29.8	0.2	2.6	0.5	0.2	1.0	37.6	0.6	1.3	0.5	2.1	2.3	1.2	45.7	0.9	56.3	0.0	0.1	0.2	2.8	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.4	0.0	0.4	1.8	1.6	3.7	1.7	1.9	1.4	1.5	3.1	3.4	0.6
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		410000000	410000000	"Actin filaments"	"Actin filaments"	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavourable (6.73e-6)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.39e-5)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	67.5	33.7	43.2	28.3	36.6	47.8	43.5	58.1	53.7	77.1	58.2	62.8	63.4	50.9	47.3	65.5	62.6	42.8	61.1	82.2	35.2	23.3	62.6	32.9	42.2	29.1	91.6	83.2	36.0	33.5	67.9	52.3	118.6	47.0	54.7	95.1	40.5	71.3	94.6	97.2	73.3	61.1	30.0	72.1	55.6	51.6	30.3	56.9	44.1	58.8	57.6	82.0	109.5	88.6	67.5	48.9	64.7	91.0	46.6	76.5	68.0	61.0	69.0	106.6	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020053	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"	"Nucleoplasm, Intermediate filaments"	"HPA020053: AB_1858280"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.8	0.0	53.0	0.0	12.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	70.5	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.2	0.9	39.6	5.6	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	Vesicles	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	2.9	0.0	0.3	0.5	0.5	0.1	1.4	0.0	0.5	1.2	0.2	8.0	0.4	4.3	1.7	11.2	3.2	9.2	0.1	23.8	1.3	0.5	7.8	0.1	1.6	0.0	1.3	0.1	7.1	0.2	4.6	2.6	0.3	1.3	0.2	0.8	0.3	0.2	0.0	13.2	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.1	4.0	0.7	0.2	10.8	0.1	2.4	0.4	4.2	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					25000000	25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.7	0.0	0.0	0.0	2.3	2.0	3.7	2.6	1.0	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0.0	0.6	1.0	1.7	0.4	1.3	0.0	0.7	2.4	1.6	0.0	0.0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	25000000	25000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	61.9	85.2	23.1	25.5	58.3	76.0	34.0	75.5	70.5	52.6	40.1	55.3	74.8	55.3	32.5	69.7	140.2	32.9	100.6	51.7	81.9	73.0	27.7	79.9	95.6	66.7	68.7	84.6	53.9	66.4	77.0	58.3	46.2	46.5	53.3	71.9	50.2	57.2	103.1	49.1	104.0	24.0	78.3	64.4	67.3	44.0	50.3	18.0	81.4	66.2	51.2	63.5	47.6	55.4	54.3	35.1	101.8	93.5	27.0	76.2	47.0	78.8	60.0	75.3	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0
WNT10A		ENSG00000135925	"Wnt family member 10A"	Q9GZT5	2	218880363-218899581	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 24.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.0;HaCaT: 46.2;HDLM-2: 19.0;RPTEC TERT1: 8.9;U-266/70: 24.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.9"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.4"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.2"	HPA013898	Uncertain				"Secreted to extracellular matrix"					"HPA013898: AB_1858847"	"unprognostic (2.99e-4)"	"unprognostic (4.31e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (9.52e-2)"	"unprognostic (6.64e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.82e-1)"	0.9	0.4	0.5	10.6	2.5	0.6	0.8	0.1	1.7	2.0	4.2	0.3	2.3	5.5	0.3	1.7	10.5	1.8	0.9	0.6	1.5	0.9	3.6	0.3	1.9	3.3	0.3	0.0	1.0	0.1	0.0	6.0	5.0	0.1	2.2	1.5	3.4	8.0	7.5	0.9	12.4	3.0	1.1	0.1	4.2	3.7	0.6	0.6	2.1	0.3	24.8	10.2	8.0	3.7	1.1	8.4	0.0	0.0	0.0	1.4	0.1	5.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.0	0.9	3.6	0.0	46.2	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	8.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	24.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	1.1	0.4	0.1	0.0	0.0	0.0	8.4	1.4	0.1	0.5	2.5	0.1	1.7	1.5	0.9	0.3	0.0	0.1	0.6
ZC3H12A	"FLJ23231, MCPIP1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474552-37484379	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.7;tongue: 56.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;RT4: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favourable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	11.7	8.4	0.8	15.0	2.9	58.7	8.2	1.3	1.3	6.4	13.3	2.9	5.6	7.0	5.0	6.9	25.2	8.1	22.6	6.3	2.1	0.7	6.7	10.7	21.0	11.3	1.8	0.7	7.1	6.8	1.0	4.6	8.1	3.8	16.1	4.2	3.0	10.9	6.3	11.8	23.1	14.1	8.5	2.6	10.9	11.0	3.4	1.1	8.3	4.0	56.9	34.8	17.0	22.2	6.1	2.6	8.9	2.1	5.5	5.5	2.3	3.7	2.7	0.3	1.7	1.4	2.1	3.1	2.7	24.4	1.7	2.3	3.0	8.5	4.2	11.6	2.6	8.2	1.1	17.5	1.0	8.6	1.7	1.1	8.9	4.7	2.0	2.2	1.8	4.4	9.0	15.2	2.7	2.0	2.1	7.0	1.6	4.5	1.7	4.0	2.1	2.4	2.5	1.1	2.5	4.4	30.2	0.8	0.5	5.4	8.7	0.6	3.0	2.5	2.0	5.3	2.9	3.8	4.1	5.6	2.0	3.1	12.0	4.7	1.0	1.8	2.1	5.8	5.4	2.1	5.5	5.2	2.2	3.3	2.6	6.1	1.3	2.5	8.9	5.5	1.9	2.5	2.8	2.3	0.8	2.9	1.3	1.3	2.1	0.7	1.8	0.7	3.8	1.1
